US20030157550A1 - Kit for direct RT-PCR on oligonucleotide-immobilized PCR microplates - Google Patents

Kit for direct RT-PCR on oligonucleotide-immobilized PCR microplates Download PDF

Info

Publication number
US20030157550A1
US20030157550A1 US10/404,988 US40498803A US2003157550A1 US 20030157550 A1 US20030157550 A1 US 20030157550A1 US 40498803 A US40498803 A US 40498803A US 2003157550 A1 US2003157550 A1 US 2003157550A1
Authority
US
United States
Prior art keywords
pcr
mrna
immobilized
microplates
oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/404,988
Inventor
Masato Mitsuhashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/404,988 priority Critical patent/US20030157550A1/en
Publication of US20030157550A1 publication Critical patent/US20030157550A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]

Definitions

  • PCR Polymerase chain reaction
  • RT-PCR reverse transcription-polymerase chain reaction
  • thermostable polymerase has activities of both reverse transcriptase and DNA polymerase, both steps can be performed simultaneously in a single tube without changing the buffer system (Myers T W, Gelfand D H, “Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase”, Biochemistry 1991;30:7661-6).
  • Myers T W, Gelfand D H “Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase”, Biochemistry 1991;30:7661-6.
  • it still requires purification of total RNA or mRNA from cells and tissues, which takes additional time-consuming, and labor-intensive step(s).
  • RT-PCR is a very useful technology in various fields including diagnostic molecular pathology (Bortolin S, et al., “Quantitative RT-PCR combined with time-resolved fluorometry for determination of BCR-ABL mRNA”, Clin Chem 1996:42:1924-9).
  • diagnostic molecular pathology Bostolin S, et al., “Quantitative RT-PCR combined with time-resolved fluorometry for determination of BCR-ABL mRNA”, Clin Chem 1996:42:1924-9.
  • steps involved in the analysis of RT-PCR collection of cells, purification of RNA/mRNA, cDNA synthesis, PCR, and quantitation of PCR products.
  • RNA molecules are the critical first step for the successful RT-PCR, and this requires labor-intensive multiple manipulations to eliminate or inactivate endogenous or contaminated ribonuclease (RNase) in cells and tissues.
  • RNase ribonuclease
  • recent PCR technologies allow researchers to continuously monitor the quantity of PCR products with various in-line or off-line verification procedures of amplified PCR products (Morris T, et al., “Rapid reverse transcription-PCR detection of hepatitis C virus RNA In serum by using the TaqMan fluorogenic detection system”, J Clin Microbiol 1996:34:p2933-6, Wittwer C T, et al., “The LightCycler: A microvolume multisample fluorimeter with rapid temperature control”, BioTechniques 1997:22:171-181), lack of a simplified RNA preparation system prevents full automation of RT-PCR.
  • oligonucleotide-immobilized microplates to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR (PCR microplates)
  • PCR microplates capturing of mRNA and reverse transcription-polymerase chain reaction (RT-PCR) can be conducted on the same plates.
  • RT-PCR reverse transcription-polymerase chain reaction
  • PCR microplates such as those made of polypropylene, polyolefine, or polycarbonate, because of their fluorescent characteristics, immobilized oligonucleotide, hybridized mRNA, and synthesized cDNA are quantitated fluorometrically by using nucleic acid stain or enzymatically by producing fluorescence or chemiluminescence.
  • the PCR microplates can also capture mRNA from crude cell lysates without purification of RNA or mRNA.
  • hybridized mRNA can be successfully used for one-step RT-PCR with rTth polymerase or two-step RT-PCR with reverse transcription followed by PCR
  • two-step RT-PCR exhibits surprisingly higher sensitivity than one-step RT-PCR. This is surprising because two-step RT-PCR requires an inefficient solid phase reverse transcription reaction, whereas one-step RT-PCR is conducted in a more efficient liquid phase reaction by first dissociating mRNA from the PCR microplates.
  • cDNA synthesized from mRNA captured by immobilized oligonucleotide on the PCR microplates can be used more than once, thereby amplifying plural times different or the same portions of the cDNA by using appropriate primers.
  • This multiple-PCR system wherein multiple PCRs are synthesized from the cDNA on the PCR microplates, is useful in basic research, diagnostics, and drug screening, with potential application to future automation.
  • cell lysate is prepared by vigorous homogenization processes which are not only time-consuming and labor-intensive, but also cause fluctuation of the amount of recovered mRNA.
  • the present invention in combination with the PCR microplates, by placing target cells on a filter plane evenly and passing a lysis buffer through the cell layer on the filter without disturbing the cells, it is possible to drastically simplify the preparation of cell lysate and significantly stabilize the yield of recovered cytosolic RNA. It is very convenient if the microplate and the filter plate are available as a kit for direct RT-PCR.
  • a lysis buffer In the above, a lysis buffer, wash buffer, reagents for RT-PCR/PCR, and PBS are commercially available or can readily be prepared so that they need not be included in the kit. However, for convenience, a lysis buffer may be included in the kit for releasing cytosolic mRNA present in the cells when passing through the cell layer on the filter plate.
  • the lysis buffer comprises a mild detergent for destructing cell membranes but maintaining nuclei to be intact and a reagent for inhibiting RNase activity or inactivating RNase, said lysis buffer having a pH and salt concentration for hybridization.
  • the PCR microplates and filter plates can drastically and surprisingly simplify the entire process of RT-PCR from the preparation of cell lysate to measuring specific PCR products with high reliability.
  • this technology is highly useful in various molecular analyses including basic research, diagnostics, and drug screening, with potential application to future automation.
  • FIG. 1 is a graph showing quantities of oligo(dT) immobilized onto oligonucleotide-immobilized polystyrene/polyolefine microplates, indicating that approximately 69% of applied oligonucleotides (10 pmol) were immobilized onto the surface of the microplates.
  • FIG. 2A is a graph showing mRNA specificity of the PCR microplates, wherein YOYO-1 fluorescent intensity indicates high specificity to mRNA ( ⁇ ) over DNA ( ⁇ ), rRNA ( ⁇ ), and tRNA ( ⁇ ).
  • FIG. 2B is a graph showing mRNA specificity of the PCR microplates, wherein alkaline phosphatase substrate (ATTOPHOSTM) indicates high specificity to mRNA ( ⁇ ) over DNA ( ⁇ ), rRNA ( ⁇ ), and tRNA ( ⁇ ).
  • ATTOPHOSTM alkaline phosphatase substrate
  • FIG. 3 is a graph showing reversible hybridization of mRNA on the PCR microplates, wherein YOYO-1 fluorescent intensity indicates sufficient reversibility of mRNA hybridization.
  • FIG. 4A shows the results of agarose gel electrophoresis showing RT-PCR products from the captured mRNA in crude cell lysates with the expected size of 168 base pairs.
  • FIG. 4B shows the results of agarose gel electrophoresis showing insignificant false PCR from contaminated genomic DNA in the plates, wherein the band disappeared after being washed with boiling DEPC (diethylpyrocarbonate) water, but not after being washed with 55° C. DEPC water.
  • DEPC diethylpyrocarbonate
  • FIG. 4C shows the results of agarose gel electrophoresis showing PCR conducted with or without reverse transcription.
  • FIG. 5A is a graph showing hybridized mRNA measured by YOYO-1 at different dilutions of cell suspension.
  • the upper inset shows the results of agarose gel electrophoresis showing hybridized mRNA measured by one-step RT-PCR using rTth polymerase.
  • the lower inset shows the results of agarose gel electrophoresis showing hybridized mRNA measured by two-step RT-PCR using rTth polymerase.
  • FIG. 5B is a graph showing hybridized mRNA measured by ATTOPHOSTM fluorescence at different dilutions of cell suspension.
  • FIG. 6A is a graph showing well-to-well variation of the amounts of immobilized oligonucleotides and hybridized rabbit globin mRNA, measured by YOYO-1 fluorescence.
  • FIG. 6B is a graph showing well-to-well variation of the amounts of synthesized cDNA from captured rabbit globin mRNA measured by ATTOPHOSTM fluorescence.
  • FIG. 7 is a graph showing well-to-well variation of the amounts of PCR products inter-assays and intra-assays (upper and lower insets).
  • FIG. 8 is a graph showing storage stability of the PCR microplates, wherein the amounts of cDNA synthesis were determined by ATTOPHOSTM fluorescence.
  • FIG. 9 is a graph showing measurement of mRNA and the results of agarose gel electrophoresis of PCR amplification of ⁇ -actin from various cultured cells which were subjected to lysis on a glass fiber filter to capture mRNA on oligo(dT)-immobilized polypropylene microplates.
  • oligonucleotide-immobilized microplates to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR
  • PCR microplates oligonucleotide-immobilized microplates to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR
  • RT-PCR reverse transcription-polymerase chain reaction
  • the PCR microplates can also capture mRNA from crude cell lysates without purification of RNA or mRNA. What makes PCR using microplates possible is the use of PCR microplates to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR.
  • oligonucleotide-immobilized polystyrene microplates such as GENEPLATE® (AGCT, Irvine, Calif.) cannot be used for PCR because polystyrene's heat stability is low.
  • PCR microplates usable in the present invention include, but are not limited to, oligonucleotide-immobilized microplates made of polypropylene, polyolefine, or polycarbonate, and other microplates made of heat resistant polymer or resin which can be used in thermal cycles of PCR.
  • polyolefine microplates may be preferred due to their surface characteristics allowing secure immobilization of oligonucleotides.
  • Oligonuleotides immobilized on microplates include, but are not limited to, oligo(dT) and other oligonuleotides specific to mRNA or target RNA.
  • Appropriate sequences can be identified by using HYBsimulatorTM software (AGCT, Irvine, Calif.) using hybridization simulation against GenBank primate database (Mitsuhashi M, et al., “Oligonucleotide probe design—a new approach”, Nature 1994:367:759-61, Hyndman D, et al., “Software to determine optimal oligonucleotide sequences based on hybridization simulation data”, BioTechniques 1996:20:1090-7). See also U.S. Pat. No.
  • the amount of immobilized oligonucleotides can be as high as 10-100 pmol per well (normally 10-30 pmol).
  • oligonucleotides cannot be immobilized thereon easily.
  • some manufacturers produce PCR microplates for molecular biological applications, which can allow researchers to conduct high throughput PCR.
  • a company such as Hitachi Chemical Research Center (Irvine, Calif.) can pretreat any commercially available PCR plates to allow oligonucleotides to be immobilized thereonto. Accordingly, this oligonucleotide-immobilized polypropylene (or polyolefine or polycarbonate) plate has recently become available (AGCT, Irvine, Calif.).
  • PCR microplates can advantageously be used for PCR.
  • PCR microplates have low capacity for nonspecific absorption of proteins and DNA/RNA, and resistance to organic chemicals (i.e. phenol/chloroform). These characteristics can be maintained even when oligonucleodites are immobilized thereonto.
  • oligonucleotide-immobilized PCR microplates Another advantage of oligonucleotide-immobilized PCR microplates is the strict specificity to mRNA, but not to rRNA, tRNA or DNA, eliminating the potential problem of false PCR amplification from contaminated genomic DNA, whereas cellulose or beads often contain detectable amounts of rRNA, tRNA and DNA. Furthermore, less variation among wells and plates, excellent stability, and availability of various quality control protocols make this technology very competitive.
  • Oligonucleotide-immobilized polystyrene microplates have been, shown to exhibit a wide variety of applications, which include the capture of total and specific mRNA, ss-cDNA and ds-cDNA synthesis, quantitation of specific mRNA, and sense and antisense mRNA synthesis.
  • oligonucleotide-immobilized PCR microplates can also be used for the same purposes as PS microplates. See U.S. Pat. No. 5,656,462, issued Aug. 12, 1997 to Keller C, et al., entitled “Method for synthesizing polynucleotide immobilized support”, which is incorporated hereby by reference herein.
  • PCR microplates An interesting feature of PCR microplates is their fluorescent characteristics. Although PCR plates are cloudy and not completely transparent compared to PS plates, fluorescence measurement of YOYOTM-1 or equivalent dyes exhibited better performance in PCR microplates than in PS microplates (Ogura M, Mitsuhashi M, “Screening method for a large quantity of polymerase chain reaction products by measuring YOYO-1 fluorescence on 96-well polypropylene plates”, Anal Biochem 1994:218:458-9). See also U.S. Pat. No. 5,545,528, issued Aug.
  • the amounts of both immobilized oligonucleotides i.e., captured mRNA and synthesized cDNA, can be determined fluorometrically without using radioactive materials.
  • immobilized oligonucleotide, hybridized mRNA, synthesized cDNA, and PCR products are quantitated fluorometrically by using nucleic acid stain or enzymatically by producing fluorescence or chemiluminescence, e.g., ATTOPHOSTM or LUMIPHOSTM.
  • the nucleic acid stains include, but are not limited to, a fluorescent dye selected from the group consisting of 1,1,′-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)-bis-4-[3-methyl-2,3-dihydro-(benzo-1,3-oxazole)-2-methylidene]-quinoliumetraiodide (YOYOTM-1), 1,1′-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)-bis-4-[3-methyl-2,3-dihydro-(benzo-1,3-thiazole)-2-methylidene]-quinoliumetraiodide (TOTOTM-1), 1,1′-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)-bis-4-[3-methyl-2,3-dihydro-(benzo-1,3-thiazole)-2-propenylidene]-quinoliume
  • oligonucleotide-immobilized PCR microplate As a oligonucleotide-immobilized PCR microplate, oligo(dT)-immobilized polypropylene/polyolefine microplate GENEPLATE®-PP (Hitachi Chemical Research Center, Irvine, Calif.) was used. However, oligonucleotide-immobilized PCR microplates are not limited to the above, and include any oligonucleotide-immobilized microplates to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR.
  • RT-PCR there are roughly two ways to perform RT-PCR: one-step RT-PCR and two-step RT-PCR.
  • one-step RT-PCR with rTth polymerase or optimal combination of reverse transcriptase and DNA polymerase (TitanTM, one tube RT-PCR kit, Boehringer Mannheim, Indianapolis, Ind.), RT-PCR can be performed on the oligonucleotide-immobilized PCR microplate without changing the buffer.
  • RT-PCR after capturing mRNA by hybridization of mRNA and immobilized oligo(dT), mRNA is removed to a RT-PCR buffer, and RT-PCR can be performed.
  • PCR is conducted by using heat stable DNA polymerase, e.g., either rTth or Taq polymerase with an appropriate buffer.
  • PCR is conducted in a thermal cycler with, e.g., 60 cycles of 94° C. denaturation for 1 min, 60° C. annealing for 1 min followed by 72° C. extension for 1 min, by using the same oligonucleotide-immobilized PCR microplates as used for hybridization.
  • RT-PCR when PCR is conducted from synthesized cDNA on the oligonucleotide-immobilized PCR microplates (two-step RT-PCR), RT-PCR can be approximately 10,000-fold more sensitive than conventional one-step RT-PCR, and transcript can be detected from cell lysates containing only 100 cells. This is very surprising because two-step RT-PCR requires inefficient solid phase reverse transcription reaction, whereas one-step RT-PCR is conducted in more efficient liquid phase reaction by first dissociating mRNA from the oligonucleotide-immobilized PCR microplates.
  • primers are used for dimer formation during reverse transcription. More primer dimers are formed in one-step PCR than two-step RT-PCR. Although hybridization efficiency is lower in two-step RT-PCR than one-step RT-PCR, primer dimers formed during initial reverse transcription phase exist throughout PCR in two-step RT-PCR, thereby drastically increasing RT-PCR sensitivity.
  • cDNA synthesized from mRNA captured by immobilized oligonucleotide on the oligonucleotide-immobilized PCR microplate can be used more than once, i.e., cDNA on the oligonucleotide-immobilized PCR microplate is quite stable.
  • This interesting feature allows reamplification by the same immobilized cDNA to amplify plural times different or the same portions of the cDNA of interest by using appropriate primers.
  • This multiple PCR system wherein multiple PCRs are synthesized from the cDNA on the oligonucleotide-immobilized PCR microplates, is useful in basic research, diagnostics, and drug screening, with potential application to future automation.
  • cell lysate is prepared by disrupting cells with a lysis buffer to release cytosolic mRNA, followed by centrifugation. Supernatants are used for hybridization. This vigorous homogenization process is not only time-consuming and labor-intensive, but also causes fluctuation of the amount of recovered mRNA.
  • By placing cells on a filter membrane evenly and passing a lysis buffer through the cell layer on the filter membrane without mechanical homoginization of the cells it is possible to drastically simplify the preparation of cell lysate and significantly stabilize the yield of recovered cytosolic RNA.
  • cells are transferred to a filter plate and cells are trapped onto its membrane by vacuum aspiration, positive pressure, or centrifugation.
  • the filter plate is then assembled on top of a oligonucleotide-immobilized PCR microplate having plural wells, and Lysis buffer is added to each well to mildly destruct cell membranes.
  • Lysis buffer is added to each well to mildly destruct cell membranes.
  • cell lysate containing cytosolic mRNA are transferred to the oligonucleotide-immobilized PCR microplate for hybridization. After hybridization at room temperature for 1 hour, for example, RT-PCR can be conducted in automated instrument.
  • a filter or membrane of the filter plate includes, but is not limited to, glass fiber, polypropylene or polyolefine mesh, wool, and other membranes which have a pore size such that target cells can be trapped without any leakage of cells from the membrane, but cytosolic mRNA can pass therethrough.
  • glass fiber Grade 934AH, Cambridge Technology, Inc. Watertown, Mass.
  • Whatman GF/F grade glass fiber memberane most of cultured cells and blood leukocyte can be trapped.
  • glass fiber plates are preferable.
  • the configuration of the filter plate needs to correspond to that of the oligonucleotide-immobilized PCR microplate with respect to, e.g., the number of wells wherein the wells of the filter plate are communicated with the respective wells of the oligonucleotide-immobilized PCR microplate when subjected to centrifugation.
  • the maximum capacity of cells per well is normally 10 4 to 10 7 .
  • the cell lysate can be passed through the membrane of the filter plate with the aid of force generated by means of centrifugation, vacuum, or positive pressure.
  • the force necessary to pass the cell lysate through the membrane is easily determined by simple experiments.
  • the lysis buffer comprises a detergent for destructing cell membranes, RNase inhibitor for inhibiting RNase activity or deactivating or destroying RNase, and pH control agent and salt for hybridization.
  • RNase must be active in the lysis buffer.
  • a mild detergent e.g., NP-40 or TRITONTM-X.
  • the above-described lysis buffer is useful and can be used for oligonucleotide-immobilized PCR microplates without the use of filter plates.
  • the protocols of this system include, but are not limited to, the following:
  • Step 1 Transfer Cells from Culture Plate to Filter Plate
  • Step 2 Transfer Cell Lysate from Filter Plate to Oligonucleotide-Immobilized PCR Microplate for Hybridization
  • lysis buffer e.g., 10 mM Tris, pH 8.0, 1 mM EDTA, 0.5 M NaCl, 0.5% NP-40, 20 mM vanadyl ribonucleoside complex, RNase-free
  • centrifuge e.g., 1,500 ⁇ g for 10 min.
  • Step 3 RT-PCR and Post-PCR Analysis
  • wash buffer e.g., 10 mM Tris, pH 8.0, 1 mM EDTA, 0.3 M NaCl, RNase-free.
  • Philadelphia chromosome found frequently in chronic myelogenous leukemia (CML) is a reciprocal translocation of ABL protooncogene from chromosome 9 to a portion of the BCR gene in chromosome 22 [t(9;22)(q34;q11)] (Wehnert M S, et al., “A rapid scanning strip for triand dinucleotide short tandem repeats”, Nucleic Acids Res 1994:22:1701-4).
  • Specific RT-PCR amplification of BCR-ABL mRNA from peripheral blood cells or bone marrow cells provides a highly sensitive and quantitative methodology for the detection of residual leukemic cells.
  • RNA or mRNA is first purified from cell suspension.
  • oligonucleotide-immobilized PCR microplates may be accepted as a platform for various molecular analyses including basic research, diagnostics, and drug screening, with potential application to future automation, especially in combination with filter plates.
  • RNA was prepared by automated instrument (MAGEXTRACTORTM MFX-2000, Toyobo, Osaka, Japan). In brief, cell pellets were suspended in kit-supplied caotropic agents, and placed in MAGEXTRACTOR, where RNA was absorbed to the surface of silica felite particles followed by magnet separation. RNA was then automatically eluted to 40 ⁇ l of low salt buffer, and was stored at ⁇ 80° C. in a freezer until use. The final RNA was analyzed by agarose gel electrophoresis to confirm 18s and 28s rRNA bands.
  • Primer design and synthesis Primers for cd4465 (sense: 5′-agtttcggagcggatgaatgc-3′, antisense: 5′-ggggcatcagaattttggttga-3′), rabbit globin mRNA (sense: 5′-cgtggagaggatgttcttgg-3′, antisense: 5′-aacgatatttggaggtcagcac-3′) and bcr-abl (sense: 5′-gaccaactcgtgtgtgaaactcca-3′, antisense: 5′-aaagtcagatgctactggccgct-3′) were designed by HYBsimulatorTM software (AGCT, Irvine, Calif.) using hybridization simulation against GenBank primate database (Mitsuhashi M, et al., Nature 1994:367:759-61, Hyndman D, et al., BioTech
  • the sense primer was located at bcr axon 2 and the antisense primer was located at abl axon 2.
  • Primers were synthesized by DNA synthesizer (380B, Applied Biosystem, Foster City), according to the manufacturer's protocol.
  • One-Step RT-PCR Template DNA/RNA, 300 ⁇ mol/L each of dATP, dGTP, dCTP and dTTP, 1 ⁇ EZ buffer, 2 mmol/L Mn(OAc) 2 , 0.5 ⁇ mol/L each of primer, and 0.1 ⁇ l rTth polymerase were mixed in a final volume of 5-50 ⁇ l, and overlayered with one drop of nuclease free mineral oil (Sigma). PCR was conducted in a thermal cycler (MJ Research, Watertown, Mass.) with 1 cycle of reverse transcription at 60° C. for 30 min and 94° C. denaturation for 1 min, followed by 40 cycles of 60° C.
  • a thermal cycler MJ Research, Watertown, Mass.
  • PCR products were analyzed by a 2.0% agarose gel electrophoresis with 0.5 ⁇ g/ml ethidium bromide in an electrophoresis chamber. Photographic images were recorded on Polaroid films (667, Cambridge, Mass.).
  • Two-Step RT-PCR After hybridization, captured mRNA was reverse transcribed to cDNA by replacing biotin-dUTP with 10 mmol/L dTTP. Reactants were removed by aspiration, and PCR was conducted by using either rTth or Taq polymerase.
  • the buffer contained 1 ⁇ buffer, 1.25 mmol/L MgCl 2 , 300 ⁇ mol/L each of dATP, dGTP, dCTP and dTTP, 0.5 ⁇ mol/L each of primer, and 0.5 ⁇ l Taq polymerase in a final volume of 10-50 ⁇ l.
  • PCR was conducted in a thermal cycler (MJ Research) with 60 cycles of 94° C. denaturation for 1 min, 60° C. annealing for 1 min followed by 72° C. extension for 1 min.
  • GENUNCTM PP microplates (Nunc, Naparville, Ill.) treated at Hitachi Chemical Research Center, Irvine, Calif., were obtained from AGCT, Irvine, Calif., and oligonucleotides were immobilized thereonto. Oligonucleotide concentrations were determined before and after immobilization as 1.0 OD 260 unit equals to 30 ⁇ g/ml, and the amounts of immobilized oligonucleotides were calculated by subtracting one value from another.
  • YOYO-1 was diluted in TE (10 mmol/L Tris, pH 8.0, 1 mmol/L EDTA) in a final dilution of 1:1000, and applied to GENEPLATE®-PP microplates.
  • the fluorescence was determined by CYTOFLUORTM 2300 (Millipore, Bedford, Mass.) with excitation and emission wavelengths of 485 nm (bandwidth 20 nm) and 530 nm (band width 25 nm), respectively, as previously described (Miura Y, et al., Clin Chem 1996:42:1758-64, Miura Y, at al., Cancer Lett 1997:116:139-44).
  • FIG. 1 is a graph showing quantities of oligo(dT) immobilized onto the oligonucleotide-immobilized PCR microplates. Oligonucleotide concentrations were determined before and after immobilization as 1.0 OD 260 , and the amounts of immobilized oligonucleotides were calculated by subtracting one value from another ( ⁇ ). In parallel experiments, 1:1000 dilution of YOYO-1 was added to each well and its fluorescence was determined ( ⁇ ). Bars indicate the % immobilization from applied oligo(dT) 20 . Each data point was the mean from triplicate determinations.
  • the fluorescence of the oligonucleotide-immobilized PCR microplates was significantly increased and reached a plateau when more than 10 pmol of oligonucleotides were applied.
  • FIG. 1 ( ⁇ ) In further quantitating the actual amounts of immobilized oligonucleotides on the oligonucleotide-immobilized PCR microplates, as shown in FIG. 1 ( ⁇ ), 21.1 pmol of oligonucleotides were immobilized after 100 pmol of oligonucleotides were applied to each well.
  • the amounts of immobilized oligonucleotides were saturated to 10-20 pmol, when more than 10 pmol of oligonucleotides were applied. Approximately 69% of applied oligonucleotides (10 pmol) were immobilized onto the surface of the microplates (FIG. 1, bar graph).
  • FIG. 2A is a graph showing mRNA specificity of the oligonucleotide-immobilized PCR microplates, wherein YOYO-1 fluorescent intensity indicates high specificity to mRNA ( ⁇ ) over DNA ( ⁇ ), rRNA ( ⁇ ), and tRNA ( ⁇ ).
  • FIG. 2B is a graph showing mRNA specificity of the oligonucleotide-immobilized PCR microplates, wherein substrate ATTOPHOSTM indicates high specificity to mRNA ( ⁇ ) over DNA ( ⁇ ), rRNA ( ⁇ ), and tRNA ( ⁇ ).
  • YOYOTM-1 was diluted in TE (10 mmol/L Tris, pH 8.0, 1 mmol/L EDTA) in a final dilution of 1:1000, and applied to each well, and the fluorescence was determined by CYTOFLUORTM 2300.
  • TE 10 mmol/L Tris, pH 8.0, 1 mmol/L EDTA
  • each well was resuspended in 50 ⁇ l of cDNA synthesis buffer (50 mmol/L Tris, pH 8.3, containing 75 mmol/L KCl, 3 mmol/L MgC12, 10 mmol/L DTT, 10 mmol/L each of dATP, dGTP, dCTP, 250 ⁇ mol/L biotin-dUTP, and 400 U of MMLV reverse transcriptase), and incubated at 37° C. for 1 hour.
  • cDNA synthesis buffer 50 mmol/L Tris, pH 8.3, containing 75 mmol/L KCl, 3 mmol/L MgC12, 10 mmol/L DTT, 10 mmol/L each of dATP, dGTP, dCTP, 250 ⁇ mol/L biotin-dUTP, and 400 U of MMLV reverse transcriptase
  • wash buffer (10 mmol/L Tris, pH 7.6, containing 300 mmol/L NaCl and 10 mmol/L Tween 20
  • 50 ⁇ l of wash buffer containing 1:1000 dilution of streptavidin-alkaline phosphatase conjugates and incubated at room temperature for 30 min.
  • 50 ⁇ l of substrate (ATTOPHOSTM) was added and incubated at room temperature for 20 min.
  • the reaction was terminated by adding an equal volume (50 ⁇ l) of 100 mmol/L EDTA, and the fluorescence was determined by CYTOFLUORTM 2300. Each data point was the mean ⁇ S.D. from triplicate determinations.
  • FIG. 2A significant YOYOTM-1 fluorescence was obtained from the wells where more than 100 ng of mRNA was applied, whereas YOYOTM-1 fluorescence was not increased in the wells of rRNA, tRNA and DNA even when as many as 10 ⁇ g was applied.
  • the specificity of quantitative cDNA synthesis on the oligonucleotide-immobilized PCR microplates was also tested as described above.
  • FIG. 2B significant ATTOPHOSTM fluorescence was obtained from the well where more than 0.1 ng/well of mRNA was applied, but not from the wells of rRNA, tRNA and DNA even when as many as 10 ⁇ g was applied.
  • FIG. 3 is a graph showing reversible hybridization of mRNA on the oligonucleotide-immobilized PCR microplates.
  • One ⁇ g of rabbit globin mRNA or 20 ⁇ g of total liver RNA was suspended in 50 ⁇ l of hybridization buffer and applied to the well of the oligonucleotide-immobilized PCR microplates. After hybridization at room temperature for 1 hour, wells were washed three times with DEPC water at different temperatures (25° C., 55° C. or boiling).
  • YOYOTM-1 was then applied to each well, and the fluorescence was determined by CYTOFLUORTM 2300 as described above (Miura Y, et al., Clin Chem 1996:42:1758-64). Each data point was the mean ⁇ S.D. from triplicate determinations. As shown in FIG. 3, YOYOTM-1 fluorescence was reduced to the basal levels by adding boiling DEPC water.
  • cDNA synthesis buffer 50 mmol/L Tris, pH 8.3, containing 75 mmol/L KCl, 3 mmol/L MgCl 2 , 10 mmol/L DTT, 10 mmol/L each of dATP, dGTP, dCTP, 250 ⁇ mol/L biotin-dUTP, and 400 U of MMLV reverse transcriptase
  • cDNA synthesis buffer 50 mmol/L Tris, pH 8.3, containing 75 mmol/L KCl, 3 mmol/L MgCl 2 , 10 mmol/L DTT, 10 mmol/L each of dATP, dGTP, dCTP, 250 ⁇ mol/L biotin-dUTP, and 400 U of MMLV reverse transcriptase
  • wash buffer (10 mmol/L Tris, pH 7.6, containing 300 mmol/L NaCl and 10 mmol/L Tween 20
  • 50 ⁇ l of wash buffer containing 1:1000 dilution of streptavidin-alkaline phosphatase conjugates was added and incubated at room temperature for 30 min.
  • 50 ⁇ l of substrate (ATTOPHOSTM, 1 ⁇ concentration) was added and incubated at room temperature for 20 min.
  • reaction was terminated by adding an equal volume (50 ⁇ l) of 100 mmol/L EDTA, and fluorescence was determined by CYTOFLUORTM 2300 (Millipore) with excitation and emission wavelengths of 485 nm (bandwidth 20 nm) and 560 nm (band width 25 nm), respectively.
  • the plates are not saturated even when as much as 500 ng of mRNA is applied, which also represents approximately 500 ⁇ g of total RNA or 10 7 cells per small surface area of 96 well plates. This is more than enough for the majority of experiments.
  • RNA was prepared by automated instrument as described in the Methods. After hybridization, RT-PCR was conducted in a thermal cycler with 1 cycle of reverse transcription at 60° C. for 30 min and 94° C. denaturation for 1 min, followed by 40 cycles of 60° C. annealing/extension for 1 min and 94° C. of denaturation for 1 min, as described in the Methods. Lane 4 was a control cd4465 DNA.
  • FIG. 4A (lane 1), BCR-ABL transcript was successfully amplified from the captured mRNA in crude cell lysates with the expected size of 168 base pairs.
  • the size of PCR products was identical to that of PCR products from purified total RNA in the same cells (FIG. 4A, lane 3). Phenol/chloroform treated cell lysates exhibited thicker PCR products than VRC-containing cell lysates (FIG. 4A, lane 2).
  • PCR was conducted with or without reverse transcription. That is, in FIG. 4C, after total RNA was hybridized, cDNA was synthesized in one tube (+) and one tube was left without reverse transcription ( ⁇ ). PCR was then conducted with Taq polymerase in the presence of 1.25 mM MgCl 2 with 60 cycles of 94° C. denaturation for 1 min, 60° C. annealing for 1 min followed by 72° C. extension for 1 were separated by 2.0% agarose gel electrophoresis followed by staining with ethidium bromide. Mk indicates a 100 bp ladder. As shown in FIG. 4C, PCR products of BCR-ABL transcript were not amplified from the wells of negative reverse transcription even under low stringent conditions with a higher Mg concentration, whereas significant amounts of PCR products were obtained from the wells of positive reverse transcription.
  • an advantage of the oligonucleotide-immobilized PCR microplates is the strict specificity to mRNA, but not to rRNA, tRNA or DNA (FIGS. 2A, 2B, 4 A, 4 B, 4 C), eliminating the potential problem of false PCR amplification from contaminated genomic DNA, whereas cellulose or beads often contain detectable amounts of rRNA, tRNA and DNA.
  • cDNA was synthesized from captured mRNA using MMLV reverse transcriptase and immobilized oligo(dT) as a primer in the presence of biotin dUTP, followed by quantitation of cDNA synthesis, as described above.
  • cDNA was synthesized on the oligonucleotide-immobilized PCR microplates by replacing biotin-dUTP with unlabeled dTTP, and PCR was conducted with rTth polymerase, as shown above (Inset, lower). The PCR products were separated by 2.0% agarose gel electrophoresis followed by staining with ethidium bromide. M indicates a 100 bp ladder. Each data point was the mean ⁇ S.D. from triplicate determinations.
  • RT-PCR from synthesized cDNA on the oligonucleotide-immobilized PCR microplates is approximately 100,000-fold more sensitive than conventional one-step RT-PCR, and bcr-abl transcript was detected from cell lysates containing only 10 cells (FIG. 5A, top inset).
  • bcr-abl transcript was detected from cell lysates containing only 10 cells (FIG. 5A, top inset).
  • primer dimers are used for dimer formation during reverse transcription.
  • two-step RT-PCR these primer dimers can be removed when the reaction mixture was switched from cDNA synthesis to PCR, whereas primer dimers formed during the initial reverse transcription phase exist throughout PCR.
  • FIGS. 6A and 6B variation of the amounts of immobilized oligonucleotides (FIG. 6A ⁇ ), hybridized rabbit globin mRNA (FIG. 6A ⁇ ), and synthesized cDNA from captured rabbit globin mRNA (FIG. 6B ⁇ ) were all less than 10-15% within a single microplate (Intra-assay) or multiple lots of microplates (Inter-assay). More importantly, the variation of the amount of PCR products in these intra- and inter-assays were also within 10% (FIG. 7). In FIG. 6A ⁇ ), hybridized rabbit globin mRNA (FIG. 6A ⁇ ), and synthesized cDNA from captured rabbit globin mRNA (FIG. 6B ⁇ ) were all less than 10-15% within a single microplate (Intra-assay) or multiple lots of microplates (Inter-assay). More importantly, the variation of the amount of PCR products in these intra- and inter-assays were also within 10% (FIG. 7
  • oligonucleotide-immobilized PCR microplates were stored at room temperature ( ⁇ ), 55° C. ( ⁇ ) or 72° C. ( ⁇ ) for 2, 8 or 15 days.
  • One hundred ng of rabbit globin mRNA was then applied to each well for hybridization, followed by cDNA synthesis in the presence of biotin-dUTP.
  • ATTOPHOSTM fluorescence was then determined in a fluorescent plate reader, as described above. Each data point was the mean ⁇ S.D. from triplicate determinations.
  • K562 cells (10 4 -10 6 ) were suspended in Lysis buffer and were applied to the oligonucleotide-immobilized PCR microplates for hybridization.
  • the captured mRNA was converted to cDNA with MMLV reverse transcriptase as described above.
  • some wells were treated identically but without MMLV reverse transcriptase.
  • bcr-abl transcript was amplified by PCR with Taq polymerase, as described above (1st bcr-abl). After PCR, each well was washed with boiling DEPC water five times, and PCR was repeated with the same primer set (2nd bcr-abl). PCR was then repeated a third time with primer pair from G3PDH (3rd G3PDH).
  • PCR products were separated by 2.0% agarose gel electrophoresis, followed by staining with ethidium bromide.
  • the agarose gel electrophoresis indicates that PCR products of bcr-abl and G3PDH transcripts were not amplified from the wells of negative reverse transcription, indicating no “false” PCR products from contaminating genomic cDNA in the plates.
  • the agarose gel electrophoresis confirms that bcr-abl and G3PDH transcripts were reamplified plural times from immobilized cDNAs from wells.
  • Various human cultured cell lines were used in this experiment: K562 leukemic, U937 leukemic, CaRI colon cancer, HepGII hepatoma, KatolII stomach cancer, and CRL 5800 lung adenocarcinoma (American Type Culture Collection, Rockville, Md.).
  • a 96-well filter plate with a single layer was made of glass fiber (Cambride Technology grade 934AH, Brandel, Gaithersburg, Md.) in order to trap cells thereon.
  • the maximum capacity of cells trapped on the single layer of glass fiber filter membranes in each well of the 96-well filter plate was determined.
  • lysis buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 0.5 M NaCl, 0.5% NP-40 detergent, and 20 mM vanadyl ribonucleoside complex (VRC, Gibco-BRL, Geithersburg, Md.)
  • VRC vanadyl ribonucleoside complex
  • the oligonucleotide-immobilized PCR microplate was washed twice with a wash buffer (10 mM Tris, pH 8.0, 1 mM EDTA, and 0.5 M NaCl). At this stage, total mRNA was captured in each well of the oligonucleotide-immobilized PCR microplate for analysis. Because of the heat-stable characteristics of the oligonucleotide-immobilized PCR microplate, the oligonucleotide-immobilized PCR microplates were directly subjected to PCR without transfer of mRNA to PCR vessels.
  • the first analysis was to amplify housekeeping genes from captured mRNA.
  • the cDNA was synthesized by adding RT-buffer (50 mM Tris, pH 8.3, containing 75 mM KCl, 3 mM MgCl 2 , and 10 mM DTT; 10 mM of each dNTP; and 100 U of MMLV reverse transcriptase (Gibco-BRL), and incubated at 37° C. for 1 hour.
  • RT-buffer 50 mM Tris, pH 8.3, containing 75 mM KCl, 3 mM MgCl 2 , and 10 mM DTT; 10 mM of each dNTP; and 100 U of MMLV reverse transcriptase (Gibco-BRL)
  • PCR was then conducted on the same plate, by replacing RT-buffer with PCR-buffer (10 ⁇ PCR buffer, 1.5 mM MgCl 2 , 100 ⁇ M of dNTPs, 1.5 units of Taq DNA polymerase (Perkin Elmer, Fostercity, Calif.), 0.5 ⁇ M each of upstream sense primer and downstream antisense primer of human ⁇ -actin (Clontech, Palo Alto, Calif.) in a final volume of 20 ⁇ L.
  • PCR was conducted in a thermal cycler (MJ Research, PTC-100, Watertown, Mass.) with 35 cycles of 45 seconds at 94° C., 45 seconds at 60° C. and 2 minutes at 72° C.
  • PCR products were analyzed in a 1.0% agarose gel electrophoresis with 0.5 ⁇ g/mL ethidium bromide.
  • FIG. 9 shows that lane M, 100 bp DNA ladder; lane 1 K562; lane 2, U937; lane 3, CaRI; lane 4, HepGII; lane 5, KatolII; lane 6, CRL5800
  • ⁇ -actin gene was successfully amplified from various cultured cells. Since intron sequences exist between sense and antisense primers, the size of ⁇ -actin PCR products were equal to that of intron-free mRNA. Furthermore, when starting PCR without cDNA synthesis, the ⁇ -actin gene was not amplified, suggesting that PCR was mRNA-specific, and not derived from contaminated DNA.
  • rabbit globin mRNA was used as a control as previously described (Tominaga K, et al., Clin Chem 1996:1750-1757, 1996). As shown in FIG. 9, captured mRNA from 10 4 cells was approximately 5 ng from 5 different cell lines.
  • cytosolic fraction was collected after hybridization, and treated with two rounds of phenol/chloroform/isoamyl alcohol extraction followed by ethanol precipitation. RNA was then analyzed by agarose gel electrophoresis. As shown in FIG. 9 (right inset: Lane M, ⁇ Hind III; lane 1, K562; lane 2, U937; lane 3, CaRI; lane 4, HepGII; lane 5, KatolII; lane 6, CRL5800), 18s and 28s rRNA bands were clearly present in all cells even after 1 hour incubation at room temperature, suggesting that simple cytosolic fraction in the presence of VRC was essentially free from RNase activity.
  • RT-PCR from starting cell suspension can be conducted using just two plates; the glass fiber filter plate and the oligo(dT)-immobilized polypropylene/polyolefine plate.
  • the 96-well format allows researchers to conduct RT-PCR in high throughput fashion with potential full automation.
  • PCR products were analyzed by agarose gel electrophoresis, however, PCR products may be quantitated continuously by TaqMan system (Morris T, et al., J Clin Microbiol 34:p2933-6, 1996). This experiment proved that this system is a useful tool for high throughput RT-PCR.

Abstract

The entire process of reverse transcription-polymerase chain reaction (RT-PCR) is simplified by using oligonucleotide-immobilized microplates made of, e.g., polypropylene, to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR. RT-PCR is preferably conducted in solid-phase. Capturing of mRNA and RT-PCR can be conducted in the same plates. The cDNA synthesized from the mRNA captured on the microplates can be used more than once. Further, in combination with the microplates, a filter plate is used for the preparation of cell lysates wherein target cells are placed on the filter plate, and a lysis buffer is passed through the cell layer on the filter to transfer cell lysate directly to the microplate via well-to-well communication.

Description

    BACKGROUND OF THE INVENTION
  • Polymerase chain reaction (PCR) following cDNA synthesis from mRNA (reverse transcription-polymerase chain reaction, RT-PCR) to analyze gene expression of any specific mRNA in cells and tissues has become common technique, because of its better sensitivity and less labor-intensive manipulations than the traditional Northern blot (Kawasaki E S, Wang A M, “Detection of gene expression. In: Erlich, EA. PCR technology”, New York: [0001] Stockton, 1989;89-97). Furthermore, because recently available recombinant Tth thermostable polymerase has activities of both reverse transcriptase and DNA polymerase, both steps can be performed simultaneously in a single tube without changing the buffer system (Myers T W, Gelfand D H, “Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase”, Biochemistry 1991;30:7661-6). However, it still requires purification of total RNA or mRNA from cells and tissues, which takes additional time-consuming, and labor-intensive step(s).
  • It has been reported that mRNA is successfully captured by an oligo(dT)immobilized polystyrene (PS) microplate (GENEPLATE®, Hitachi Chemical Co., Japan, and AGCT, Irvine, Calif.) (Mitsuhashi M, et al., “Gene manipulation on plastic plates”, [0002] Nature 1992:357:519-20, Miura Y, et al., “Fluorometric determination of total mRNA with oligo(dT) immobilized on microtiter plates”, Clin Chem 1996:42:1758-64, Miura Y, et al., “Rapid cytocidal and cytostatic chemosensitivity test by measuring total amount of mRNA”, Cancer Lett 1997:116:139-44) followed by single- and double-stranded cDNA synthesis on the plate (Tominaga K, et al., “Colorimetric ELISA measurement of specific mRNA on immobilized-oligonucleotide-coated microtiter plates by reverse transcription with biotinylated mononucleotides”, Clin Chem 1996:42:1750-7). Once double stranded cDNA is formed on a PS microplate of GENEPLATE®, sense stranded cDNA can be removed and used as a template for multiple PCR experiments (Ishikawa T, et al., “Construction of cDNA bank from biopsy specimens for multiple gene analysis of cancer”, Clin Chem 1997:43:764-70). Unfortunately, PCR cannot be performed on this PS microplate, because of its heat instability during the denaturing step in PCR cycles. Although heat stable polypropylene (PP) tubes and microplates are primary vessels for PCR, it is difficult to immobilize oligonucleotides onto a PP surface, because of its extremely chamically stable surface characteristics. However, oligo(dT)-immobilized polypropylene plates have recently become available.
  • As described above, RT-PCR is a very useful technology in various fields including diagnostic molecular pathology (Bortolin S, et al., “Quantitative RT-PCR combined with time-resolved fluorometry for determination of BCR-ABL mRNA”, [0003] Clin Chem 1996:42:1924-9). However, there are many steps involved in the analysis of RT-PCR; collection of cells, purification of RNA/mRNA, cDNA synthesis, PCR, and quantitation of PCR products. In particular, the purification of intact RNA molecules is the critical first step for the successful RT-PCR, and this requires labor-intensive multiple manipulations to eliminate or inactivate endogenous or contaminated ribonuclease (RNase) in cells and tissues. Although recent PCR technologies allow researchers to continuously monitor the quantity of PCR products with various in-line or off-line verification procedures of amplified PCR products (Morris T, et al., “Rapid reverse transcription-PCR detection of hepatitis C virus RNA In serum by using the TaqMan fluorogenic detection system”, J Clin Microbiol 1996:34:p2933-6, Wittwer C T, et al., “The LightCycler: A microvolume multisample fluorimeter with rapid temperature control”, BioTechniques 1997:22:171-181), lack of a simplified RNA preparation system prevents full automation of RT-PCR.
  • SUMMARY OF THE INVENTION
  • In order to simplify the entire process of gene expression analysis, by using oligonucleotide-immobilized microplates to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR (PCR microplates), capturing of mRNA and reverse transcription-polymerase chain reaction (RT-PCR) can be conducted on the same plates. Heretofore, microplates were never used for PCR due to insufficient thermal stability, and thus, RT-PCR processes were time-consuming and labor-intensive. In using PCR microplates such as those made of polypropylene, polyolefine, or polycarbonate, because of their fluorescent characteristics, immobilized oligonucleotide, hybridized mRNA, and synthesized cDNA are quantitated fluorometrically by using nucleic acid stain or enzymatically by producing fluorescence or chemiluminescence. The PCR microplates can also capture mRNA from crude cell lysates without purification of RNA or mRNA. [0004]
  • Although hybridized mRNA can be successfully used for one-step RT-PCR with rTth polymerase or two-step RT-PCR with reverse transcription followed by PCR, two-step RT-PCR exhibits surprisingly higher sensitivity than one-step RT-PCR. This is surprising because two-step RT-PCR requires an inefficient solid phase reverse transcription reaction, whereas one-step RT-PCR is conducted in a more efficient liquid phase reaction by first dissociating mRNA from the PCR microplates. [0005]
  • In addition, cDNA synthesized from mRNA captured by immobilized oligonucleotide on the PCR microplates can be used more than once, thereby amplifying plural times different or the same portions of the cDNA by using appropriate primers. This multiple-PCR system, wherein multiple PCRs are synthesized from the cDNA on the PCR microplates, is useful in basic research, diagnostics, and drug screening, with potential application to future automation. [0006]
  • Further, conventionally, cell lysate is prepared by vigorous homogenization processes which are not only time-consuming and labor-intensive, but also cause fluctuation of the amount of recovered mRNA. In the present invention, in combination with the PCR microplates, by placing target cells on a filter plane evenly and passing a lysis buffer through the cell layer on the filter without disturbing the cells, it is possible to drastically simplify the preparation of cell lysate and significantly stabilize the yield of recovered cytosolic RNA. It is very convenient if the microplate and the filter plate are available as a kit for direct RT-PCR. In the above, a lysis buffer, wash buffer, reagents for RT-PCR/PCR, and PBS are commercially available or can readily be prepared so that they need not be included in the kit. However, for convenience, a lysis buffer may be included in the kit for releasing cytosolic mRNA present in the cells when passing through the cell layer on the filter plate. In the above, the lysis buffer comprises a mild detergent for destructing cell membranes but maintaining nuclei to be intact and a reagent for inhibiting RNase activity or inactivating RNase, said lysis buffer having a pH and salt concentration for hybridization. [0007]
  • Because of the above features, the PCR microplates and filter plates can drastically and surprisingly simplify the entire process of RT-PCR from the preparation of cell lysate to measuring specific PCR products with high reliability. Thus, this technology is highly useful in various molecular analyses including basic research, diagnostics, and drug screening, with potential application to future automation.[0008]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a graph showing quantities of oligo(dT) immobilized onto oligonucleotide-immobilized polystyrene/polyolefine microplates, indicating that approximately 69% of applied oligonucleotides (10 pmol) were immobilized onto the surface of the microplates. [0009]
  • FIG. 2A is a graph showing mRNA specificity of the PCR microplates, wherein YOYO-1 fluorescent intensity indicates high specificity to mRNA () over DNA (▪), rRNA (Δ), and tRNA (∇). [0010]
  • FIG. 2B is a graph showing mRNA specificity of the PCR microplates, wherein alkaline phosphatase substrate (ATTOPHOS™) indicates high specificity to mRNA () over DNA (▪), rRNA (Δ), and tRNA (∇). [0011]
  • FIG. 3 is a graph showing reversible hybridization of mRNA on the PCR microplates, wherein YOYO-1 fluorescent intensity indicates sufficient reversibility of mRNA hybridization. [0012]
  • FIG. 4A shows the results of agarose gel electrophoresis showing RT-PCR products from the captured mRNA in crude cell lysates with the expected size of 168 base pairs. [0013]
  • FIG. 4B shows the results of agarose gel electrophoresis showing insignificant false PCR from contaminated genomic DNA in the plates, wherein the band disappeared after being washed with boiling DEPC (diethylpyrocarbonate) water, but not after being washed with 55° C. DEPC water. [0014]
  • FIG. 4C shows the results of agarose gel electrophoresis showing PCR conducted with or without reverse transcription. [0015]
  • FIG. 5A is a graph showing hybridized mRNA measured by YOYO-1 at different dilutions of cell suspension. The upper inset shows the results of agarose gel electrophoresis showing hybridized mRNA measured by one-step RT-PCR using rTth polymerase. The lower inset shows the results of agarose gel electrophoresis showing hybridized mRNA measured by two-step RT-PCR using rTth polymerase. [0016]
  • FIG. 5B is a graph showing hybridized mRNA measured by ATTOPHOS™ fluorescence at different dilutions of cell suspension. [0017]
  • FIG. 6A is a graph showing well-to-well variation of the amounts of immobilized oligonucleotides and hybridized rabbit globin mRNA, measured by YOYO-1 fluorescence. [0018]
  • FIG. 6B is a graph showing well-to-well variation of the amounts of synthesized cDNA from captured rabbit globin mRNA measured by ATTOPHOS™ fluorescence. [0019]
  • FIG. 7 is a graph showing well-to-well variation of the amounts of PCR products inter-assays and intra-assays (upper and lower insets). [0020]
  • FIG. 8 is a graph showing storage stability of the PCR microplates, wherein the amounts of cDNA synthesis were determined by ATTOPHOS™ fluorescence. [0021]
  • FIG. 9 is a graph showing measurement of mRNA and the results of agarose gel electrophoresis of PCR amplification of β-actin from various cultured cells which were subjected to lysis on a glass fiber filter to capture mRNA on oligo(dT)-immobilized polypropylene microplates. [0022]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • PCR Microplates [0023]
  • In the present invention, oligonucleotide-immobilized microplates to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR (PCR microplates) are used, wherein the capture of mRNA and reverse transcription-polymerase chain reaction (RT-PCR) can be conducted on the same plates. The PCR microplates can also capture mRNA from crude cell lysates without purification of RNA or mRNA. What makes PCR using microplates possible is the use of PCR microplates to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR. For example, conventional oligonucleotide-immobilized polystyrene microplates such as GENEPLATE® (AGCT, Irvine, Calif.) cannot be used for PCR because polystyrene's heat stability is low. PCR microplates usable in the present invention include, but are not limited to, oligonucleotide-immobilized microplates made of polypropylene, polyolefine, or polycarbonate, and other microplates made of heat resistant polymer or resin which can be used in thermal cycles of PCR. In the above, polyolefine microplates may be preferred due to their surface characteristics allowing secure immobilization of oligonucleotides. Oligonuleotides immobilized on microplates include, but are not limited to, oligo(dT) and other oligonuleotides specific to mRNA or target RNA. Appropriate sequences can be identified by using HYBsimulator™ software (AGCT, Irvine, Calif.) using hybridization simulation against GenBank primate database (Mitsuhashi M, et al., “Oligonucleotide probe design—a new approach”, [0024] Nature 1994:367:759-61, Hyndman D, et al., “Software to determine optimal oligonucleotide sequences based on hybridization simulation data”, BioTechniques 1996:20:1090-7). See also U.S. Pat. No. 5,556,749, issued Sep. 17, 1996 to Mitsuhashi M, et al., entitled “Oigo probe designstation: a computerized method for designing optimal DNA probes”, which is incorporated hereby by reference herein. The amount of immobilized oligonucleotides can be as high as 10-100 pmol per well (normally 10-30 pmol).
  • Because of stable surface characteristics of polypropylene, oligonucleotides cannot be immobilized thereon easily. However, recently, some manufacturers produce PCR microplates for molecular biological applications, which can allow researchers to conduct high throughput PCR. In addition, a company such as Hitachi Chemical Research Center (Irvine, Calif.) can pretreat any commercially available PCR plates to allow oligonucleotides to be immobilized thereonto. Accordingly, this oligonucleotide-immobilized polypropylene (or polyolefine or polycarbonate) plate has recently become available (AGCT, Irvine, Calif.). [0025]
  • As compared with PS plates or tubes unsuitable for 94° C. heat denaturing step in PCR, PCR microplates can advantageously be used for PCR. Like widely used PCR microtubes in molecular biological experiments, PCR microplates have low capacity for nonspecific absorption of proteins and DNA/RNA, and resistance to organic chemicals (i.e. phenol/chloroform). These characteristics can be maintained even when oligonucleodites are immobilized thereonto. [0026]
  • Another advantage of oligonucleotide-immobilized PCR microplates is the strict specificity to mRNA, but not to rRNA, tRNA or DNA, eliminating the potential problem of false PCR amplification from contaminated genomic DNA, whereas cellulose or beads often contain detectable amounts of rRNA, tRNA and DNA. Furthermore, less variation among wells and plates, excellent stability, and availability of various quality control protocols make this technology very competitive. [0027]
  • Oligonucleotide-immobilized polystyrene microplates have been, shown to exhibit a wide variety of applications, which include the capture of total and specific mRNA, ss-cDNA and ds-cDNA synthesis, quantitation of specific mRNA, and sense and antisense mRNA synthesis. oligonucleotide-immobilized PCR microplates can also be used for the same purposes as PS microplates. See U.S. Pat. No. 5,656,462, issued Aug. 12, 1997 to Keller C, et al., entitled “Method for synthesizing polynucleotide immobilized support”, which is incorporated hereby by reference herein. [0028]
  • An interesting feature of PCR microplates is their fluorescent characteristics. Although PCR plates are cloudy and not completely transparent compared to PS plates, fluorescence measurement of YOYO™-1 or equivalent dyes exhibited better performance in PCR microplates than in PS microplates (Ogura M, Mitsuhashi M, “Screening method for a large quantity of polymerase chain reaction products by measuring YOYO-1 fluorescence on 96-well polypropylene plates”, [0029] Anal Biochem 1994:218:458-9). See also U.S. Pat. No. 5,545,528, issued Aug. 13, 1996 to Mitsuhashi M, et al., entitled “Rapid screening method of gene amplification products in polypropylene plates”, which is incorporated hereby by reference herein. This allows for conducting various analysis quite easily. For example, the amounts of both immobilized oligonucleotides, i.e., captured mRNA and synthesized cDNA, can be determined fluorometrically without using radioactive materials.
  • Detection of Fluorescence [0030]
  • Because of the fluorescent characteristics of polypropylene, polyolefine, or polycarbonate plates, immobilized oligonucleotide, hybridized mRNA, synthesized cDNA, and PCR products are quantitated fluorometrically by using nucleic acid stain or enzymatically by producing fluorescence or chemiluminescence, e.g., ATTOPHOS™ or LUMIPHOS™. The nucleic acid stains include, but are not limited to, a fluorescent dye selected from the group consisting of 1,1,′-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)-bis-4-[3-methyl-2,3-dihydro-(benzo-1,3-oxazole)-2-methylidene]-quinoliumetraiodide (YOYO™-1), 1,1′-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)-bis-4-[3-methyl-2,3-dihydro-(benzo-1,3-thiazole)-2-methylidene]-quinoliumetraiodide (TOTO™-1), 1,1′-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)-bis-4-[3-methyl-2,3-dihydro-(benzo-1,3-thiazole)-2-propenylidene]-quinoliumetraiodide (TOTO™-3), SYBR®-Green I, II, and PicoGreen®. See also U.S. Pat. No. 5,545,528 described above. Accordingly, this oligonucleotide-immobilized polypropylene, polyolefine, or polycarbonate plate has recently become available. [0031]
  • In the following experiments, as a oligonucleotide-immobilized PCR microplate, oligo(dT)-immobilized polypropylene/polyolefine microplate GENEPLATE®-PP (Hitachi Chemical Research Center, Irvine, Calif.) was used. However, oligonucleotide-immobilized PCR microplates are not limited to the above, and include any oligonucleotide-immobilized microplates to which oligonucleotides are securely immobilized and which can be subjected to thermal cycles of PCR. [0032]
  • Two-Step RT-PCR or Solid-Phase RT-PCR [0033]
  • There are roughly two ways to perform RT-PCR: one-step RT-PCR and two-step RT-PCR. In one-step RT-PCR, with rTth polymerase or optimal combination of reverse transcriptase and DNA polymerase (Titan™, one tube RT-PCR kit, Boehringer Mannheim, Indianapolis, Ind.), RT-PCR can be performed on the oligonucleotide-immobilized PCR microplate without changing the buffer. As another one-step RT-PCR, after capturing mRNA by hybridization of mRNA and immobilized oligo(dT), mRNA is removed to a RT-PCR buffer, and RT-PCR can be performed. In contrast, in two-step RT-PCR, after hybridization on oligonucleotide-immobilized PCR microplates, captured mRNA is reverse transcribed to cDNA on the same microplates, reactants are removed by aspiration, and PCR is conducted by using heat stable DNA polymerase, e.g., either rTth or Taq polymerase with an appropriate buffer. In the above, PCR is conducted in a thermal cycler with, e.g., 60 cycles of 94° C. denaturation for 1 min, 60° C. annealing for 1 min followed by 72° C. extension for 1 min, by using the same oligonucleotide-immobilized PCR microplates as used for hybridization. It is believed that one of ordinary skill in the art expects that one-step or liquid-phase RT-PCR is better than two-step RT-PCR with respect to PCR efficiency. However, surprisingly, when PCR is conducted from synthesized cDNA on the oligonucleotide-immobilized PCR microplates (two-step RT-PCR), RT-PCR can be approximately 10,000-fold more sensitive than conventional one-step RT-PCR, and transcript can be detected from cell lysates containing only 100 cells. This is very surprising because two-step RT-PCR requires inefficient solid phase reverse transcription reaction, whereas one-step RT-PCR is conducted in more efficient liquid phase reaction by first dissociating mRNA from the oligonucleotide-immobilized PCR microplates. One explanation may be as follows: It is believed that primers are used for dimer formation during reverse transcription. More primer dimers are formed in one-step PCR than two-step RT-PCR. Although hybridization efficiency is lower in two-step RT-PCR than one-step RT-PCR, primer dimers formed during initial reverse transcription phase exist throughout PCR in two-step RT-PCR, thereby drastically increasing RT-PCR sensitivity. [0034]
  • Reamplification by Immobilized cDNA (Multiple-PCR System) [0035]
  • cDNA synthesized from mRNA captured by immobilized oligonucleotide on the oligonucleotide-immobilized PCR microplate can be used more than once, i.e., cDNA on the oligonucleotide-immobilized PCR microplate is quite stable. This interesting feature allows reamplification by the same immobilized cDNA to amplify plural times different or the same portions of the cDNA of interest by using appropriate primers. This multiple PCR system, wherein multiple PCRs are synthesized from the cDNA on the oligonucleotide-immobilized PCR microplates, is useful in basic research, diagnostics, and drug screening, with potential application to future automation. [0036]
  • High Throughput RT-PCR System [0037]
  • Conventionally, cell lysate is prepared by disrupting cells with a lysis buffer to release cytosolic mRNA, followed by centrifugation. Supernatants are used for hybridization. This vigorous homogenization process is not only time-consuming and labor-intensive, but also causes fluctuation of the amount of recovered mRNA. By placing cells on a filter membrane evenly and passing a lysis buffer through the cell layer on the filter membrane without mechanical homoginization of the cells, it is possible to drastically simplify the preparation of cell lysate and significantly stabilize the yield of recovered cytosolic RNA. [0038]
  • Namely, in the present invention, in order to simplify the entire RT-PCR process starting from cells on culture plates, cells are transferred to a filter plate and cells are trapped onto its membrane by vacuum aspiration, positive pressure, or centrifugation. The filter plate is then assembled on top of a oligonucleotide-immobilized PCR microplate having plural wells, and Lysis buffer is added to each well to mildly destruct cell membranes. After these two-plate sandwiches are centrifuged, cell lysate containing cytosolic mRNA are transferred to the oligonucleotide-immobilized PCR microplate for hybridization. After hybridization at room temperature for 1 hour, for example, RT-PCR can be conducted in automated instrument. In the above, a filter or membrane of the filter plate includes, but is not limited to, glass fiber, polypropylene or polyolefine mesh, wool, and other membranes which have a pore size such that target cells can be trapped without any leakage of cells from the membrane, but cytosolic mRNA can pass therethrough. For example, using glass fiber (Grade 934AH, Cambridge Technology, Inc. Watertown, Mass.) or Whatman GF/F grade glass fiber memberane, most of cultured cells and blood leukocyte can be trapped. In the above, glass fiber plates are preferable. Further, because the filter plate is mounted on the top of a oligonucleotide-immobilized PCR microplate, the configuration of the filter plate needs to correspond to that of the oligonucleotide-immobilized PCR microplate with respect to, e.g., the number of wells wherein the wells of the filter plate are communicated with the respective wells of the oligonucleotide-immobilized PCR microplate when subjected to centrifugation. The maximum capacity of cells per well is normally 10[0039] 4 to 107.
  • In the above, the cell lysate can be passed through the membrane of the filter plate with the aid of force generated by means of centrifugation, vacuum, or positive pressure. The force necessary to pass the cell lysate through the membrane is easily determined by simple experiments. [0040]
  • In the above, the lysis buffer comprises a detergent for destructing cell membranes, RNase inhibitor for inhibiting RNase activity or deactivating or destroying RNase, and pH control agent and salt for hybridization. In the above, RNase must be active in the lysis buffer. Further, in order to mildly destruct cell membranes so as to prevent contamination of nucleus, the use of a mild detergent is preferable (e.g., NP-40 or TRITON™-X). The above-described lysis buffer is useful and can be used for oligonucleotide-immobilized PCR microplates without the use of filter plates. [0041]
  • The protocols of this system include, but are not limited to, the following: [0042]
  • Step 1: Transfer Cells from Culture Plate to Filter Plate [0043]
  • 1. Place a filter plate onto a vacuum manifold. [0044]
  • 2. Transfer cells from culture plates to the filter plate by using, e.g., multi-channel pipettes. [0045]
  • 3. Vacuum aspirate the filter plate to trap cells onto membranes. [0046]
  • 4. Wash each well once or twice with, e.g., 50 μl each of PBS (optional). [0047]
  • Step 2: Transfer Cell Lysate from Filter Plate to Oligonucleotide-Immobilized PCR Microplate for Hybridization [0048]
  • 1. Remove the filter plate from the vacuum manifold and place it on top of the oligonucleotide-immobilized PCR microplate. [0049]
  • 2. Add, e.g., 50 μl of lysis buffer (e.g., 10 mM Tris, pH 8.0, 1 mM EDTA, 0.5 M NaCl, 0.5% NP-40, 20 mM vanadyl ribonucleoside complex, RNase-free), and centrifuge at, e.g., 1,500×g for 10 min. [0050]
  • 3. Incubate the oligonucleotide-immobilized PCR microplate at room temperature for 1 hour for hybridization between immobilized oligo(dT) and poly(A) tails of mRNA present in cytosolic fraction of cells. [0051]
  • Step 3: RT-PCR and Post-PCR Analysis [0052]
  • 1. Wash each well once or twice with, 50 μl of wash buffer (e.g., 10 mM Tris, pH 8.0, 1 mM EDTA, 0.3 M NaCl, RNase-free). [0053]
  • 2. Start RT-PCR and monitor the amount of PCR products in an automated PCR instrument. [0054]
  • According to the present invention, a rapid, inexpensive, high throughput, and easily automated method for the entire RT-PCR process starting from cells can be realized. [0055]
  • Philadelphia chromosome (Ph[0056] 1) found frequently in chronic myelogenous leukemia (CML) is a reciprocal translocation of ABL protooncogene from chromosome 9 to a portion of the BCR gene in chromosome 22 [t(9;22)(q34;q11)] (Wehnert M S, et al., “A rapid scanning strip for triand dinucleotide short tandem repeats”, Nucleic Acids Res 1994:22:1701-4). Specific RT-PCR amplification of BCR-ABL mRNA from peripheral blood cells or bone marrow cells provides a highly sensitive and quantitative methodology for the detection of residual leukemic cells. Because the detection of residual leukemic cells is one of critical indicators for the treatments of CNE, RT-PCR test of BCR-ABL mRNA is widely available in many institutions. However, in many cases, total RNA or mRNA is first purified from cell suspension. Using the present system, once cell lysates are applied to the oligonucleotide-immobilized PCR microplates for hybridization, one can proceed with not only direct RT-PCR described here, but also YOYO™-1 quantitation of total amounts of mRNA (Miura Y, et al., Clin Chem 1996:42:1758-64), which may provide additional means of normalization or quality control of tested materials. Because of its simplicity and fluorescent characteristics, oligonucleotide-immobilized PCR microplates may be accepted as a platform for various molecular analyses including basic research, diagnostics, and drug screening, with potential application to future automation, especially in combination with filter plates.
  • EXAMPLES
  • The invention will be further explained with reference to Examples shown below. Materials and methods used in the Examples are as follows: [0057]
  • Materials: Oligo(dT)-immobilized oligonucleotide-immobilized PCR microplates (GENEPLATE®-PP, Hitachi Chemical Research Center, Irvine, Calif.), YOYO™-1 (1,1′-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)-bis-4-[3-methyl-2,3-dihydro-(benzo-1,3-oxazole)-2-methylidene]-quinoliumetraiodide, Molecular Probes, Eugene, Oreg.), reagents for PCR (Taq polymerase, EZ rTth RNA-PCR kit) (Perkin Elmar, Foster City, Calif.), K562 cell line (American Type Culture Collection, Rockville, Md.), 100 bp DNA ladder, phosphate buffered saline (PBS), vanadyl ribonucleoside complex (VRC), rabbit globin mRNA, cell culture medium and appropriate antibiotics, buffer-saturated phenol (Gibco-BRL, Geithersburg, Md.), fetal bovine serum (FBS, HyClone, Logan, Utah), biotin-dUTP (Clontech, Palo Alto, Calif.), ATTOPHOS™ (alkaline phosphatase substrate, JBL Scientific, San Luis Obispo, Calif.), cd4465 DNA (Genome Systems, St. Louis, Mo.) were purchased from the designated suppliers. RNA preparation reagents for MAGEXTRACTOR™ were kindly provided by Toyobo (Osaka, Japan). All other chemicals were purchased from Sigma (St. Louis, Mo.). [0058]
  • Cell culture: K562 calls were grown in RPMI 1640 containing 10% FBS, 500 units/ml penicillin, 500 μg/ml streptomycin, and subcultured twice a week at a ratio of approximately 1:10. Cell viability was assessed by the exclusion of trypan blue, and was always more than 95%. [0059]
  • Preparation of cell lysate and total RNA: Cells were washed with PBS twice, and suspended in lysis buffer (10 mmol/L Tris, pH 7.6, 1 mmol/L EDTA, 0.1% NP-40 and 20 mmol/L VRC) on ice for 5 min to release cytosolic mRNA as previously described (Miura Y, et al., [0060] Clin Chem 1996:42:1758664). Samples were then centrifuged at 15,000×g at 4° C. for 5 min, and supernatants were applied to GENEPLATE®-PP for hybridization. In some experiments, cells were suspended in VRC-free lysis buffer, and immediately treated with an equal volume of phenol/chloroform twice to absorb proteins and nucleases. Deproteinated solutions were then subjected to hybridization.
  • When a glass fiber filter plate having 96 wells, adapted to be placed on the top of the microplates, was used to recover RNA, the above vigorous homogenization process was entirely omitted. Culture cells were transferred to the glass fiber filter plate by using multi-channel pipettes (described later). [0061]
  • Total RNA was prepared by automated instrument (MAGEXTRACTOR™ MFX-2000, Toyobo, Osaka, Japan). In brief, cell pellets were suspended in kit-supplied caotropic agents, and placed in MAGEXTRACTOR, where RNA was absorbed to the surface of silica felite particles followed by magnet separation. RNA was then automatically eluted to 40 μl of low salt buffer, and was stored at −80° C. in a freezer until use. The final RNA was analyzed by agarose gel electrophoresis to confirm 18s and 28s rRNA bands. [0062]
  • Primer design and synthesis: Primers for cd4465 (sense: 5′-agtttcggagcggatgaatgc-3′, antisense: 5′-ggggcatcagaattttggttga-3′), rabbit globin mRNA (sense: 5′-cgtggagaggatgttcttgg-3′, antisense: 5′-aacgatatttggaggtcagcac-3′) and bcr-abl (sense: 5′-gaccaactcgtgtgtgaaactcca-3′, antisense: 5′-aaagtcagatgctactggccgct-3′) were designed by HYBsimulator™ software (AGCT, Irvine, Calif.) using hybridization simulation against GenBank primate database (Mitsuhashi M, et al., [0063] Nature 1994:367:759-61, Hyndman D, et al., BioTechniques 1996:20:1090-7). In the case of bcr-abl, the sense primer was located at bcr axon 2 and the antisense primer was located at abl axon 2. Primers were synthesized by DNA synthesizer (380B, Applied Biosystem, Foster City), according to the manufacturer's protocol.
  • One-Step RT-PCR: Template DNA/RNA, 300 μmol/L each of dATP, dGTP, dCTP and dTTP, 1× EZ buffer, 2 mmol/L Mn(OAc)[0064] 2, 0.5 μmol/L each of primer, and 0.1 μl rTth polymerase were mixed in a final volume of 5-50 μl, and overlayered with one drop of nuclease free mineral oil (Sigma). PCR was conducted in a thermal cycler (MJ Research, Watertown, Mass.) with 1 cycle of reverse transcription at 60° C. for 30 min and 94° C. denaturation for 1 min, followed by 40 cycles of 60° C. annealing/extension for 1 min and 94° C. of denaturation for 1 min. After PCR was completed, PCR products were analyzed by a 2.0% agarose gel electrophoresis with 0.5 μg/ml ethidium bromide in an electrophoresis chamber. Photographic images were recorded on Polaroid films (667, Cambridge, Mass.).
  • Two-Step RT-PCR: After hybridization, captured mRNA was reverse transcribed to cDNA by replacing biotin-dUTP with 10 mmol/L dTTP. Reactants were removed by aspiration, and PCR was conducted by using either rTth or Taq polymerase. For PCR with Taq polymerase, the buffer contained 1× buffer, 1.25 mmol/L MgCl[0065] 2, 300 μmol/L each of dATP, dGTP, dCTP and dTTP, 0.5 μmol/L each of primer, and 0.5 μl Taq polymerase in a final volume of 10-50 μl. PCR was conducted in a thermal cycler (MJ Research) with 60 cycles of 94° C. denaturation for 1 min, 60° C. annealing for 1 min followed by 72° C. extension for 1 min.
  • Experiment 1: Quantitation of Immobilized Oligonucleotides [0066]
  • GENUNC™ PP microplates (Nunc, Naparville, Ill.) treated at Hitachi Chemical Research Center, Irvine, Calif., were obtained from AGCT, Irvine, Calif., and oligonucleotides were immobilized thereonto. Oligonucleotide concentrations were determined before and after immobilization as 1.0 OD[0067] 260 unit equals to 30 μg/ml, and the amounts of immobilized oligonucleotides were calculated by subtracting one value from another. In separate experiments, YOYO-1 was diluted in TE (10 mmol/L Tris, pH 8.0, 1 mmol/L EDTA) in a final dilution of 1:1000, and applied to GENEPLATE®-PP microplates. The fluorescence was determined by CYTOFLUOR™ 2300 (Millipore, Bedford, Mass.) with excitation and emission wavelengths of 485 nm (bandwidth 20 nm) and 530 nm (band width 25 nm), respectively, as previously described (Miura Y, et al., Clin Chem 1996:42:1758-64, Miura Y, at al., Cancer Lett 1997:116:139-44).
  • FIG. 1 is a graph showing quantities of oligo(dT) immobilized onto the oligonucleotide-immobilized PCR microplates. Oligonucleotide concentrations were determined before and after immobilization as 1.0 OD[0068] 260, and the amounts of immobilized oligonucleotides were calculated by subtracting one value from another (◯). In parallel experiments, 1:1000 dilution of YOYO-1 was added to each well and its fluorescence was determined (). Bars indicate the % immobilization from applied oligo(dT)20. Each data point was the mean from triplicate determinations. Although the oligonucleotide-immobilized PCR microplates were opaque and not transparent compared to conventional PS plates, as shown in FIG. 1 (), the fluorescence of the oligonucleotide-immobilized PCR microplates was significantly increased and reached a plateau when more than 10 pmol of oligonucleotides were applied. In further quantitating the actual amounts of immobilized oligonucleotides on the oligonucleotide-immobilized PCR microplates, as shown in FIG. 1 (◯), 21.1 pmol of oligonucleotides were immobilized after 100 pmol of oligonucleotides were applied to each well. The amounts of immobilized oligonucleotides were saturated to 10-20 pmol, when more than 10 pmol of oligonucleotides were applied. Approximately 69% of applied oligonucleotides (10 pmol) were immobilized onto the surface of the microplates (FIG. 1, bar graph).
  • Experiment 2: mRNA Specificity of Oligonucleotide-Immobilized PCR Microplates [0069]
  • The next series of experiments was conducted to show mRNA specificity. FIG. 2A is a graph showing mRNA specificity of the oligonucleotide-immobilized PCR microplates, wherein YOYO-1 fluorescent intensity indicates high specificity to mRNA () over DNA (▪), rRNA (Δ), and tRNA (∇). FIG. 2B is a graph showing mRNA specificity of the oligonucleotide-immobilized PCR microplates, wherein substrate ATTOPHOS™ indicates high specificity to mRNA () over DNA (▪), rRNA (Δ), and tRNA (∇). [0070]
  • In the figures, various concentrations of rabbit globin mRNA (), DNA (▪), rRNA (Δ), tRNA (∇) were suspended in 50 μl of hybridization buffer (10 mmol/L Tris, pH 8.0, 1 mmol/L EDTA, 0.5 M NaCl) and applied to the well of the oligonucleotide-immobilized PCR microplates. After hybridization at room temperature for 1 hour, each well was washed once with hybridization buffer. In FIG. 2A, YOYO™-1 was diluted in TE (10 mmol/L Tris, pH 8.0, 1 mmol/L EDTA) in a final dilution of 1:1000, and applied to each well, and the fluorescence was determined by CYTOFLUOR™ 2300. In FIG. 2B, each well was resuspended in 50 μl of cDNA synthesis buffer (50 mmol/L Tris, pH 8.3, containing 75 mmol/L KCl, 3 mmol/L MgC12, 10 mmol/L DTT, 10 mmol/L each of dATP, dGTP, dCTP, 250 μmol/L biotin-dUTP, and 400 U of MMLV reverse transcriptase), and incubated at 37° C. for 1 hour. After each well was washed three times with wash buffer (10 mmol/L Tris, pH 7.6, containing 300 mmol/L NaCl and 10 mmol/L Tween 20), 50 μl of wash buffer containing 1:1000 dilution of streptavidin-alkaline phosphatase conjugates and incubated at room temperature for 30 min. After each well was washed three times with wash buffer, 50 μl of substrate (ATTOPHOS™) was added and incubated at room temperature for 20 min. The reaction was terminated by adding an equal volume (50 μl) of 100 mmol/L EDTA, and the fluorescence was determined by CYTOFLUOR™ 2300. Each data point was the mean ±S.D. from triplicate determinations. [0071]
  • As shown in FIG. 2A, significant YOYO™-1 fluorescence was obtained from the wells where more than 100 ng of mRNA was applied, whereas YOYO™-1 fluorescence was not increased in the wells of rRNA, tRNA and DNA even when as many as 10 μg was applied. The specificity of quantitative cDNA synthesis on the oligonucleotide-immobilized PCR microplates was also tested as described above. As shown in FIG. 2B, significant ATTOPHOS™ fluorescence was obtained from the well where more than 0.1 ng/well of mRNA was applied, but not from the wells of rRNA, tRNA and DNA even when as many as 10 μg was applied. [0072]
  • Experiment 3: Quantitation of Hybridization [0073]
  • FIG. 3 is a graph showing reversible hybridization of mRNA on the oligonucleotide-immobilized PCR microplates. One μg of rabbit globin mRNA or 20 μg of total liver RNA was suspended in 50 μl of hybridization buffer and applied to the well of the oligonucleotide-immobilized PCR microplates. After hybridization at room temperature for 1 hour, wells were washed three times with DEPC water at different temperatures (25° C., 55° C. or boiling). YOYO™-1 was then applied to each well, and the fluorescence was determined by CYTOFLUOR™ 2300 as described above (Miura Y, et al., [0074] Clin Chem 1996:42:1758-64). Each data point was the mean ±S.D. from triplicate determinations. As shown in FIG. 3, YOYO™-1 fluorescence was reduced to the basal levels by adding boiling DEPC water.
  • Experiment 4: Capacity of Hybridization [0075]
  • Moreover, in order to assess the hybridization capacity, various amounts of globin mRNA, total liver RNA or cell lysates were applied to the oligonucleotide-immobilized PCR microplates for hybridization. Hybridized mRNA was then recovered from the plates by adding boiling water, and a buffer (concentration was adjusted) was applied to fresh oligonucleotide-immobilized PCR microplates for the second hybridization. In parallel experiments, known concentrations of globin mRNA were also applied as a control. The quantitative cDNA synthesis described below was then conducted, and the amount of mRNA in the solutions was determined based on the values of standard globin mRNA. The amounts of cDNA synthesis were quantitated according to the protocol published by Tominaga et al. ([0076] Clin Chem 1996:42:1750-7) with minor modification. In brief, the mRNA-hybridized oligonucleotide-immobilized PCR microplate was resuspended in 50 μl of cDNA synthesis buffer (50 mmol/L Tris, pH 8.3, containing 75 mmol/L KCl, 3 mmol/L MgCl2, 10 mmol/L DTT, 10 mmol/L each of dATP, dGTP, dCTP, 250 μmol/L biotin-dUTP, and 400 U of MMLV reverse transcriptase), and incubated at 37° C. for 1 hour. After each well was washed three times with wash buffer (10 mmol/L Tris, pH 7.6, containing 300 mmol/L NaCl and 10 mmol/L Tween 20), 50 μl of wash buffer containing 1:1000 dilution of streptavidin-alkaline phosphatase conjugates was added and incubated at room temperature for 30 min. After each well was washed three times with wash buffer, 50 μl of substrate (ATTOPHOS™, 1× concentration) was added and incubated at room temperature for 20 min. The reaction was terminated by adding an equal volume (50 μl) of 100 mmol/L EDTA, and fluorescence was determined by CYTOFLUOR™ 2300 (Millipore) with excitation and emission wavelengths of 485 nm (bandwidth 20 nm) and 560 nm (band width 25 nm), respectively.
  • As shown in Table I, approximately 50-65% of applied globin mRNA was hybridized to the plates. Applied globin mRNA did not saturate the plates even when 500 ng was used; 500 ng of globin mRNA equals approximately 1-2 pmol compared to 21 pmol of immobilized oligonucleotides. Moreover, approximately 34-48% of total RNA or cell lysates were captured by the plates when mRNA concentration was low, whereas high concentrations decreased capture efficiency, probably because of inefficient hybridization due to high viscosity. [0077]
    TABLE I
    Amounts Captured mRNA
    of total (means ± S.D.,
    Applied mRNA n = 3) % Capture
    globin
    mRNA
    500 ng 500 ng 326.7 ± 47.3 ng 65.3%
    50 ng 50 ng 32.0 ± 5.6 ng   64%
    5 ng 5 ng 2.5 ± 0.3 ng   50%
    liver RNA
    50 μg 583 ng 45.6 ± 14.2 ng  7.8%
    5 μg 58.3 ng 14.8 ± 5.2 ng 25.4%
    0.5 μg 5.83 ng 2.8 ± 0.3 ng 48.0%
    K562 cells
    105 cells 24.3 ng 4.2 ± 0.9 ng 17.2%
    104 cells 2.43 ng 0.83 ± 0.3 ng 34.1%
  • As shown above, the plates are not saturated even when as much as 500 ng of mRNA is applied, which also represents approximately 500 μg of total RNA or 10[0078] 7 cells per small surface area of 96 well plates. This is more than enough for the majority of experiments.
  • Experiment 5: RT-PCR in Oligonucleotide-Immobilized PCR Microplates [0079]
  • Human K562 leukemic cells, which express the b3a2 transcript from the Ph[0080] 1 translocation, were lysed with lysis buffer followed by centrifugation to remove cell debris and nuclear DNA. The supernatant containing cytosolic mRNA was then applied to the oligonucleotide-immobilized PCR microplates for hybridization. After 1 hour of hybridization at room temperature, unbound materials were removed by washing with hybridization buffer twice, and RT-PCR was started in the same wells.
  • That is, in FIG. 4A, 10[0081] 8 K562 cells were suspended in lysis buffer (10 mmol/L Tris, pH 7.6, 1 mmol/L EDTA, 0.1% NP-40 and 20 mmol/L VRC) on ice for 5 min to release cytosolic mRNA. Samples were then centrifuged at 15,000×g at 4° C. for 5 min, and supernatants were applied to the oligonucleotide-immobilized PCR microplates for hybridization (lane 1). In lane 2, cells were suspended in VRC-free lysis buffer, and immediately treated with an equal volume of phenol/chloroform twice to absorb proteins/nucleases. Deproteinated solutions were then subjected to hybridization. In lane 3, total RNA was prepared by automated instrument as described in the Methods. After hybridization, RT-PCR was conducted in a thermal cycler with 1 cycle of reverse transcription at 60° C. for 30 min and 94° C. denaturation for 1 min, followed by 40 cycles of 60° C. annealing/extension for 1 min and 94° C. of denaturation for 1 min, as described in the Methods. Lane 4 was a control cd4465 DNA.
  • As shown in FIG. 4A (lane 1), BCR-ABL transcript was successfully amplified from the captured mRNA in crude cell lysates with the expected size of 168 base pairs. The size of PCR products was identical to that of PCR products from purified total RNA in the same cells (FIG. 4A, lane 3). Phenol/chloroform treated cell lysates exhibited thicker PCR products than VRC-containing cell lysates (FIG. 4A, lane 2). [0082]
  • In order to analyze the false PCR from contaminated genomic DNA in the plates, mRNA was removed by 55° C. or boiling DEPC water and one-step RT-PCR was conducted. That is, in FIG. 4B, after total RNA was hybridized, wells were washed with 55° C. DEPC water or boiling [0083] DEPC water 3 times, and one-step RT-PCR was conducted. As shown in FIG. 4B, PCR products of BCR-ABL transcript when washed with disappeared when wells were washed with boiling water, but not when washed with 55° C. water. These results were comparable to that of FIG. 3.
  • In separate experiments, PCR was conducted with or without reverse transcription. That is, in FIG. 4C, after total RNA was hybridized, cDNA was synthesized in one tube (+) and one tube was left without reverse transcription (−). PCR was then conducted with Taq polymerase in the presence of 1.25 mM MgCl[0084] 2 with 60 cycles of 94° C. denaturation for 1 min, 60° C. annealing for 1 min followed by 72° C. extension for 1 were separated by 2.0% agarose gel electrophoresis followed by staining with ethidium bromide. Mk indicates a 100 bp ladder. As shown in FIG. 4C, PCR products of BCR-ABL transcript were not amplified from the wells of negative reverse transcription even under low stringent conditions with a higher Mg concentration, whereas significant amounts of PCR products were obtained from the wells of positive reverse transcription.
  • In view of the foregoing, an advantage of the oligonucleotide-immobilized PCR microplates is the strict specificity to mRNA, but not to rRNA, tRNA or DNA (FIGS. 2A, 2B, [0085] 4A, 4B, 4C), eliminating the potential problem of false PCR amplification from contaminated genomic DNA, whereas cellulose or beads often contain detectable amounts of rRNA, tRNA and DNA.
  • Experiment 6: Two-Step RT-PCR [0086]
  • Direct RT-PCR experiments were conducted at different dilutions of cell suspension. Various numbers of K562 cells were applied to the oligonucleotide-immobilized PCR microplates for hybridization. The resultant hybridized mRNA was used for either measurement of Yoyo-1, or one-step RT-PCR using rTth polymerase. That is, in FIGS. 5A and 5B, various amounts (0-6×10[0087] 6) of K562 cells were suspended in lysis, and were applied to the oligonucleotide-immobilized PCR microplates for hybridization. In FIG. 5A, the amounts of hybridized mRNA were determined by YOYO™-1 fluorescence, as described above. In parallel experiments, captured mRNA was immediately subjected to one-step RT-PCR using rTth polymerase, as described above (Inset, upper). In FIG. 5B, in another series of experiments, cDNA was synthesized from captured mRNA using MMLV reverse transcriptase and immobilized oligo(dT) as a primer in the presence of biotin dUTP, followed by quantitation of cDNA synthesis, as described above. In parallel experiments, cDNA was synthesized on the oligonucleotide-immobilized PCR microplates by replacing biotin-dUTP with unlabeled dTTP, and PCR was conducted with rTth polymerase, as shown above (Inset, lower). The PCR products were separated by 2.0% agarose gel electrophoresis followed by staining with ethidium bromide. M indicates a 100 bp ladder. Each data point was the mean ±S.D. from triplicate determinations.
  • As shown in FIG. 5B, significant ATTOPHOS™ signals were obtained even from as few as 10[0088] 4 cells, suggesting 100-fold more sensitivity than YOYO™-1. More advantageously, when PCR was conducted from synthesized cDNA on the oligonucleotide-immobilized PCR microplates. PCR band was detected from as few as 10 cells (FIG. 5A, inset bottom).
  • In view of the foregoing, RT-PCR from synthesized cDNA on the oligonucleotide-immobilized PCR microplates (Two-step RT-PCR, FIG. 5A, lower inset) is approximately 100,000-fold more sensitive than conventional one-step RT-PCR, and bcr-abl transcript was detected from cell lysates containing only 10 cells (FIG. 5A, top inset). This is surprising because two-step RT-PCR required inefficient solid phase reverse transcription reaction, whereas one-step RT-PCR was conducted in more efficient liquid phase reaction by first dissociating mRNA from the oligonucleotide-immobilized PCR microplates. Since rTth was used for both experiments, the difference was not due to the enzyme. Because more primer dimers were formed in one-step PCR than two-step RT-PCR (FIG. 5A, top and lower insets: the clear band on each lane in the top inset indicate primer dimers), it is believed that primers are used for dimer formation during reverse transcription. In two-step RT-PCR, these primer dimers can be removed when the reaction mixture was switched from cDNA synthesis to PCR, whereas primer dimers formed during the initial reverse transcription phase exist throughout PCR. [0089]
  • Experiment 7: Intra- and Inter-Assay of Oligonucleotide Immobilization, Hybridization, and cDNA Synthesis [0090]
  • In order to conduct quantitative analysis on the oligonucleotide-immobilized PCR microplates, well-to-well variation is a critical issue. One hundred pmol of oligonucleotides were applied to the oligonucleotide-immobilized PCR microplates for immobilization followed by YOYO™-[0091] 1 fluorescence determination in a fluorescent plate reader, as described above (FIG. 6A). One hundred ng of rabbit globin mRNA was applied to each well for hybridization, followed by YOYO™-1 fluorescence determination in a fluorescent plate reader, as described above (FIG. 6A▪). One hundred ng of rabbit globin mRNA was applied to each well for hybridization, followed by cDNA synthesis in the presence of biotin-dUTP. ATTOPHOS™ fluorescence was then determined in a fluorescent plate reader, as described above (FIG. 6BΔ). Each data point was the mean ±S.D. from 10 (Intra-essay) to 3 (Inter-assay) separate determinations.
  • As shown in FIGS. 6A and 6B, variation of the amounts of immobilized oligonucleotides (FIG. 6A), hybridized rabbit globin mRNA (FIG. 6A▪), and synthesized cDNA from captured rabbit globin mRNA (FIG. 6BΔ) were all less than 10-15% within a single microplate (Intra-assay) or multiple lots of microplates (Inter-assay). More importantly, the variation of the amount of PCR products in these intra- and inter-assays were also within 10% (FIG. 7). In FIG. 7, one hundred ng of rabbit globin mRNA was applied to each well for hybridization, followed by cDNA synthesis in the presence of unlabeled dTTP. PCR was then conducted with rabbit globin specific primers and Taq polymerase, as described in the Methods. The PCR products were separated by 2.0% agarose gel electrophoresis followed by staining with ethidium bromide. Right lanes indicate a 100 bp ladder. The amounts of PCR products were determined by measuring OD[0092] 260 (). Each data point was the mean ±S.D. from 10 (Intra-assay) to 3 (inter-assay) separate determinations.
  • In view of the foregoing, less variation among wells and plates, excellent stability, and availability of various quality control protocols (e.g., FIGS. 6A, 6B, [0093] 7) make this technology very competitive.
  • Experiment 8: Stability of Oligonucleotide-Immobilized PCR Microplates [0094]
  • The oligonucleotide-immobilized PCR microplates were stored at room temperature (), 55° C. (▪) or 72° C. (Δ) for 2, 8 or 15 days. One hundred ng of rabbit globin mRNA was then applied to each well for hybridization, followed by cDNA synthesis in the presence of biotin-dUTP. ATTOPHOS™ fluorescence was then determined in a fluorescent plate reader, as described above. Each data point was the mean ±S.D. from triplicate determinations. [0095]
  • As shown in FIG. 8, quantities of cDNA synthesis did not show any significant decreases even after storage at 72° C. for 15 days. [0096]
  • Experiment 9: Multiple PCRs from cDNA Synthesized on Oligonucleotide-Immobilized PCR Microplates [0097]
  • K562 cells (10[0098] 4-106) were suspended in Lysis buffer and were applied to the oligonucleotide-immobilized PCR microplates for hybridization. The captured mRNA was converted to cDNA with MMLV reverse transcriptase as described above. As controls, some wells were treated identically but without MMLV reverse transcriptase. Then bcr-abl transcript was amplified by PCR with Taq polymerase, as described above (1st bcr-abl). After PCR, each well was washed with boiling DEPC water five times, and PCR was repeated with the same primer set (2nd bcr-abl). PCR was then repeated a third time with primer pair from G3PDH (3rd G3PDH). The PCR products were separated by 2.0% agarose gel electrophoresis, followed by staining with ethidium bromide. As a result, the agarose gel electrophoresis indicates that PCR products of bcr-abl and G3PDH transcripts were not amplified from the wells of negative reverse transcription, indicating no “false” PCR products from contaminating genomic cDNA in the plates. More interestingly, the agarose gel electrophoresis confirms that bcr-abl and G3PDH transcripts were reamplified plural times from immobilized cDNAs from wells.
  • Experiment 10: Collection of Cytosolic mRNA Fraction to Oligonucleotide-Immobilized PCR Microplates from Various Cells by Glass Fiber Filter [0099]
  • Various human cultured cell lines were used in this experiment: K562 leukemic, U937 leukemic, CaRI colon cancer, HepGII hepatoma, KatolII stomach cancer, and CRL 5800 lung adenocarcinoma (American Type Culture Collection, Rockville, Md.). A 96-well filter plate with a single layer was made of glass fiber (Cambride Technology grade 934AH, Brandel, Gaithersburg, Md.) in order to trap cells thereon. In preliminary experiments, the maximum capacity of cells trapped on the single layer of glass fiber filter membranes in each well of the 96-well filter plate was determined. Various numbers of cells (10[0100] 2 to 5×108) were applied to the filter plate assembled on top of a regular 96-well microplate, and centrifuged at 500×g for 10 min. The number of cells in the passed-through fraction collected in the well of the lower plates was measured with a hemocytometer. As a result, the maximum capacity of cells per well was approximately 2×106, 2×106, 106, 5×106, 5×105 and 3×105 for K562, U937, CaRI, HepGII KatolII, and CRL 5800 cells, respectively, without any leakage of cells from glass fiber membranes.
  • In the next series of experiments, 10[0101] 5 cells were applied to the filter plate, and cells were trapped onto the membrane by vacuum aspiration. The membranes were washed twice with PBS, and placed on top of the oligo(dT)-immobilized polypropylene/polyolefine microplate (GENEPLATE®-PP, AGCT) which would subsequently be used as a oligonucleotide-immobilized PCR microplate. Fifty μL of lysis buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 0.5 M NaCl, 0.5% NP-40 detergent, and 20 mM vanadyl ribonucleoside complex (VRC, Gibco-BRL, Geithersburg, Md.)) was added to each well, and was immediately centrifuged at 500×g for 10 min to recover cytosolic RNA fraction into the oligonucleotide-immobilized PCR microplate. The lysis buffer allowed hybridization between oligo(dT) and poly(A) sequences of mRNA in the presence of RNase inhibitor VRC. After hybridization at room temperature for 1 hr, the oligonucleotide-immobilized PCR microplate was washed twice with a wash buffer (10 mM Tris, pH 8.0, 1 mM EDTA, and 0.5 M NaCl). At this stage, total mRNA was captured in each well of the oligonucleotide-immobilized PCR microplate for analysis. Because of the heat-stable characteristics of the oligonucleotide-immobilized PCR microplate, the oligonucleotide-immobilized PCR microplates were directly subjected to PCR without transfer of mRNA to PCR vessels.
  • Experiment 11: Measurement of mRNA and PCR Amplification of β-Actin from Various Cultured Cells [0102]
  • Subsequent to Experiment 10, the first analysis was to amplify housekeeping genes from captured mRNA. The cDNA was synthesized by adding RT-buffer (50 mM Tris, pH 8.3, containing 75 mM KCl, 3 mM MgCl[0103] 2, and 10 mM DTT; 10 mM of each dNTP; and 100 U of MMLV reverse transcriptase (Gibco-BRL), and incubated at 37° C. for 1 hour. PCR was then conducted on the same plate, by replacing RT-buffer with PCR-buffer (10× PCR buffer, 1.5 mM MgCl2, 100 μM of dNTPs, 1.5 units of Taq DNA polymerase (Perkin Elmer, Fostercity, Calif.), 0.5 μM each of upstream sense primer and downstream antisense primer of human β-actin (Clontech, Palo Alto, Calif.) in a final volume of 20 μL. PCR was conducted in a thermal cycler (MJ Research, PTC-100, Watertown, Mass.) with 35 cycles of 45 seconds at 94° C., 45 seconds at 60° C. and 2 minutes at 72° C. PCR products were analyzed in a 1.0% agarose gel electrophoresis with 0.5 μg/mL ethidium bromide. As shown in FIG. 9 (left insets: lane M, 100 bp DNA ladder; lane 1 K562; lane 2, U937; lane 3, CaRI; lane 4, HepGII; lane 5, KatolII; lane 6, CRL5800), β-actin gene was successfully amplified from various cultured cells. Since intron sequences exist between sense and antisense primers, the size of β-actin PCR products were equal to that of intron-free mRNA. Furthermore, when starting PCR without cDNA synthesis, the β-actin gene was not amplified, suggesting that PCR was mRNA-specific, and not derived from contaminated DNA.
  • In parallel experiments, the amounts of captured mRNA on the oligonucleotide-immobilized PCR microplate were quantitated by the method published previously from our laboratory (Tominaga K, et al., “Colorimetric ELISA measurement of specific mRNA on immobilized-oligonucleotide-coated microtiter plates by reverse transcription with biotinylated mononucleotides”, [0104] Clin Chem 1996:1750-1757, 1996) with minor modifications. In brief, the first strand cDNA was synthesized on the microplate by adding RT-buffer containing 250 μM biotin-dUTP instead of 10 mM of dTTP, and incubated at 37° C. for 1 hour. Each well was washed three times with wash buffer, and 50 μL of wash buffer containing 1:1000 dilution of streptavidin-alkaline phosphate conjugates (Clontech, Palo Alto, Calif.) were added to each well. Each well was incubated at room temperature for 30 min, and then washed three times with wash buffer. Finally 100 μL of AttoPhos (JBL Scientific, San Luis Obispo, Calif.) was added to each well and incubated at room temperature for 15 min. Fluorescence was determined in a CytoFluor 2300 (Millipore, Bedford, Mass.) at 430 nm excitation and 560 nm emission. In order to quantitate the amount of mRNA from fluorescence intensity, rabbit globin mRNA was used as a control as previously described (Tominaga K, et al., Clin Chem 1996:1750-1757, 1996). As shown in FIG. 9, captured mRNA from 104 cells was approximately 5 ng from 5 different cell lines.
  • In order to further analyze the potential degradation of mRNA during hybridization, cytosolic fraction was collected after hybridization, and treated with two rounds of phenol/chloroform/isoamyl alcohol extraction followed by ethanol precipitation. RNA was then analyzed by agarose gel electrophoresis. As shown in FIG. 9 (right inset: Lane M, λ Hind III; [0105] lane 1, K562; lane 2, U937; lane 3, CaRI; lane 4, HepGII; lane 5, KatolII; lane 6, CRL5800), 18s and 28s rRNA bands were clearly present in all cells even after 1 hour incubation at room temperature, suggesting that simple cytosolic fraction in the presence of VRC was essentially free from RNase activity.
  • In conclusion, complete RT-PCR from starting cell suspension can be conducted using just two plates; the glass fiber filter plate and the oligo(dT)-immobilized polypropylene/polyolefine plate. Furthermore, the 96-well format allows researchers to conduct RT-PCR in high throughput fashion with potential full automation. In this experiment, PCR products were analyzed by agarose gel electrophoresis, however, PCR products may be quantitated continuously by TaqMan system (Morris T, et al., [0106] J Clin Microbiol 34:p2933-6, 1996). This experiment proved that this system is a useful tool for high throughput RT-PCR.
  • It will be understood by those of skill in the art that numerous and various modifications can be made without departing from the spirit of the present invention. Therefore, it should be clearly understood that the forms of the present invention are illustrative only and are not intended to limit the scope of the present invention. [0107]
  • 1 6 1 21 DNA Artificial Sequence Primer cd4465 sense. 1 agtttcggag cggatgaatg c 21 2 22 DNA Artificial Sequence Primer cd4465 antisense. 2 ggggcatcag aattttggtt ga 22 3 20 DNA Artificial Sequence Primer for rabbit globin mRNA sense. 3 cgtggagagg atgttcttgg 20 4 22 DNA Artificial Sequence Primer for rabbit globin mRNA antisense. 4 aacgatattt ggaggtcagc ac 22 5 24 DNA Artificial Sequence Primer for bcr-able sense. 5 gaccaactcg tgtgtgaaac tcca 24 6 23 DNA Artificial Sequence Primer for bcr-able antisense. 6 aaagtcagat gctactggcc gct 23

Claims (4)

What is claimed is:
1. A kit for direct RT-PCR, comprising:
an oligonucleotide-immobilized microplate for capturing mRNA from a cell lysate, said microplate having wells to which oligonucleotides are securely immobilized, said microplate having heat-stability for thermal cycles of PCR, said oligonucleotides having nucleic acid sequences specifically complimentary to mRNA of interest present in the cell lysate; and
a filter plate for preparing a cell lysate, said filter plate having wells with a membrane having a pore size such that target cells are trapped, but cytosolic mRNA present in the cells passes therethrough, wherein the target cells are placed on the membrane, said filter plate having a configuration such that the filter plate can be mounted on top of the microplate to establish well-to-well communication between the filter plate and the microplate; wherein the filter plate is mounted on top of the microplate when in use, and an appropriate lysis buffer is passed through the cell layer on the membrane without disturbing the cells to transfer the cell lysate to the microplate, followed by RT-PCR using the microplate.
2. A kit for direct RT-PCR according to claim 1, wherein the microplate is made of polypropylene or polyolefine.
3. A kit for direct RT-PCR according to claim 1, wherein the filter plate is made of glass fiber.
4. A kit for direct RT-PCR according to claim 1, further comprising a lysis buffer for releasing cytosolic mRNA present in the cells when passing through the cell layer on the filter plate, said lysis buffer comprising a mild detergent for destructing cell membranes but maintaining nuclei to be intact and a reagent for inhibiting Rnase activity or inactivating Rnase, said lysis buffer having a pH and salt concentration for hybridization.
US10/404,988 1997-12-22 2003-03-31 Kit for direct RT-PCR on oligonucleotide-immobilized PCR microplates Abandoned US20030157550A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/404,988 US20030157550A1 (en) 1997-12-22 2003-03-31 Kit for direct RT-PCR on oligonucleotide-immobilized PCR microplates

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6839497P 1997-12-22 1997-12-22
US7162798P 1998-01-16 1998-01-16
US10/048,800 US6844158B1 (en) 1997-12-22 1998-12-22 Direct RT-PCR on oligonucleotide-immobilized PCR microplates
US10/404,988 US20030157550A1 (en) 1997-12-22 2003-03-31 Kit for direct RT-PCR on oligonucleotide-immobilized PCR microplates

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10/048,800 Division US6844158B1 (en) 1997-12-22 1998-12-22 Direct RT-PCR on oligonucleotide-immobilized PCR microplates
PCT/US1998/027293 Division WO1999032654A1 (en) 1997-12-22 1998-12-22 Direct rt-pcr on oligonucleotide-immobilized pcr microplates

Publications (1)

Publication Number Publication Date
US20030157550A1 true US20030157550A1 (en) 2003-08-21

Family

ID=27670367

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/048,800 Expired - Lifetime US6844158B1 (en) 1997-12-22 1998-12-22 Direct RT-PCR on oligonucleotide-immobilized PCR microplates
US10/404,988 Abandoned US20030157550A1 (en) 1997-12-22 2003-03-31 Kit for direct RT-PCR on oligonucleotide-immobilized PCR microplates
US10/404,033 Expired - Fee Related US7258976B2 (en) 1997-12-22 2003-03-31 Method of preparing cell lysate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/048,800 Expired - Lifetime US6844158B1 (en) 1997-12-22 1998-12-22 Direct RT-PCR on oligonucleotide-immobilized PCR microplates

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/404,033 Expired - Fee Related US7258976B2 (en) 1997-12-22 2003-03-31 Method of preparing cell lysate

Country Status (1)

Country Link
US (3) US6844158B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042784A3 (en) * 2003-10-30 2005-10-13 Hitachi Chemical Co Ltd Device and method for high-throughput quantification of mrna from whole blood
US20060024757A1 (en) * 2004-07-30 2006-02-02 Robert Hussa Detection of oncofetal fibronectin for selection of concepti
US20090137406A1 (en) * 2006-06-07 2009-05-28 Kenji Kinoshita RNA Detection Method
WO2012040500A3 (en) * 2010-09-22 2012-05-24 Hoon Dave S B Direct blood assay for detection of circulating microrna in cancer patients

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844158B1 (en) * 1997-12-22 2005-01-18 Hitachi Chemical Co., Ltd. Direct RT-PCR on oligonucleotide-immobilized PCR microplates
GB2363381B (en) * 2000-06-12 2004-11-24 Cambridge Molecular Tech Solution
US6638428B2 (en) * 2000-10-31 2003-10-28 Hitachi Chemical Research Center, Inc. Method of preventing formation of bubbles during filtration operations
WO2002066637A2 (en) * 2000-10-31 2002-08-29 Hitachi Chemical Research Center, Inc. Method for collecting and using nuclear mrna
AT500427B1 (en) * 2002-05-29 2009-02-15 Anagnostics Bioanalysis Gmbh DEVICE FOR ANALYZING INGREDIENTS OF A SAMPLE
EP1670944A4 (en) * 2003-09-19 2012-12-05 Life Technologies Corp Microplates useful for conducting thermocycled nucleotide amplification
US7460223B2 (en) * 2003-09-19 2008-12-02 Applied Biosystems Inc. Inverted orientation for a microplate
AT502549B1 (en) * 2005-10-07 2007-06-15 Anagnostics Bioanalysis Gmbh DEVICE FOR THE ANALYSIS OF LIQUID SAMPLES
US20070207483A1 (en) * 2006-03-02 2007-09-06 Bio-Rad Laboratories, Inc. BUFFERS FOR DETECTION OF mRNA SEPARATED IN A MICROFLUIDIC DEVICE
AU2007233252C1 (en) 2006-03-29 2013-05-23 Boehringer Ingelheim Animal Health USA Inc. Vaccine against Streptococci
US20080213870A1 (en) * 2007-03-01 2008-09-04 Sean Wuxiong Cao Methods for obtaining modified DNA from a biological specimen
EP2209905A4 (en) * 2007-10-17 2010-10-06 3M Innovative Properties Co Rapid detection of microorganisms
US8304185B2 (en) 2009-07-17 2012-11-06 Canon U.S. Life Sciences, Inc. Methods and systems for DNA isolation on a microfluidic device
EP2315848B1 (en) 2008-07-18 2014-12-10 Canon U.S. Life Sciences, Inc. Methods and systems for microfluidic dna sample preparation
JP5729904B2 (en) 2009-06-02 2015-06-03 キヤノン株式会社 Methods for preparing proteins, DNA, RNA from cells
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
JP5893607B2 (en) 2010-04-05 2016-03-23 プログノシス バイオサイエンシズ インコーポレイテッドPrognosys Biosciences,Inc. Spatial-encoded biological assay
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
ES2761920T3 (en) 2012-08-30 2020-05-21 Gen Probe Inc Multiphasic nucleic acid amplification
WO2014210225A1 (en) 2013-06-25 2014-12-31 Prognosys Biosciences, Inc. Methods and systems for determining spatial patterns of biological targets in a sample
CN103440837B (en) * 2013-08-14 2016-09-21 深圳市摩西尔电子有限公司 A kind of full color video display correction process method and system
US10774374B2 (en) 2015-04-10 2020-09-15 Spatial Transcriptomics AB and Illumina, Inc. Spatially distinguished, multiplex nucleic acid analysis of biological specimens
WO2017204771A2 (en) * 2016-05-27 2017-11-30 Erciyes Universitesi A system and method for identification of microorganisms
US11519033B2 (en) 2018-08-28 2022-12-06 10X Genomics, Inc. Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
CN109536585A (en) * 2018-12-10 2019-03-29 吴江近岸蛋白质科技有限公司 Method, matched reagent box and the application of cell one-step method real-time quantitative PCR
WO2020123316A2 (en) 2018-12-10 2020-06-18 10X Genomics, Inc. Methods for determining a location of a biological analyte in a biological sample
US11926867B2 (en) 2019-01-06 2024-03-12 10X Genomics, Inc. Generating capture probes for spatial analysis
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
EP4055185A1 (en) 2019-11-08 2022-09-14 10X Genomics, Inc. Spatially-tagged analyte capture agents for analyte multiplexing
WO2021092433A2 (en) 2019-11-08 2021-05-14 10X Genomics, Inc. Enhancing specificity of analyte binding
FI3891300T3 (en) 2019-12-23 2023-05-10 10X Genomics Inc Methods for spatial analysis using rna-templated ligation
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US11821035B1 (en) 2020-01-29 2023-11-21 10X Genomics, Inc. Compositions and methods of making gene expression libraries
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
US11835462B2 (en) 2020-02-11 2023-12-05 10X Genomics, Inc. Methods and compositions for partitioning a biological sample
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
US11926863B1 (en) 2020-02-27 2024-03-12 10X Genomics, Inc. Solid state single cell method for analyzing fixed biological cells
US11768175B1 (en) 2020-03-04 2023-09-26 10X Genomics, Inc. Electrophoretic methods for spatial analysis
EP4242325A3 (en) 2020-04-22 2023-10-04 10X Genomics, Inc. Methods for spatial analysis using targeted rna depletion
EP4153775A1 (en) 2020-05-22 2023-03-29 10X Genomics, Inc. Simultaneous spatio-temporal measurement of gene expression and cellular activity
EP4153776A1 (en) 2020-05-22 2023-03-29 10X Genomics, Inc. Spatial analysis to detect sequence variants
WO2021242834A1 (en) 2020-05-26 2021-12-02 10X Genomics, Inc. Method for resetting an array
AU2021283184A1 (en) 2020-06-02 2023-01-05 10X Genomics, Inc. Spatial transcriptomics for antigen-receptors
EP4025692A2 (en) 2020-06-02 2022-07-13 10X Genomics, Inc. Nucleic acid library methods
WO2021252499A1 (en) 2020-06-08 2021-12-16 10X Genomics, Inc. Methods of determining a surgical margin and methods of use thereof
WO2021252591A1 (en) 2020-06-10 2021-12-16 10X Genomics, Inc. Methods for determining a location of an analyte in a biological sample
AU2021294334A1 (en) 2020-06-25 2023-02-02 10X Genomics, Inc. Spatial analysis of DNA methylation
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
US11926822B1 (en) 2020-09-23 2024-03-12 10X Genomics, Inc. Three-dimensional spatial analysis
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
WO2022140028A1 (en) 2020-12-21 2022-06-30 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes
EP4301870A1 (en) 2021-03-18 2024-01-10 10X Genomics, Inc. Multiplex capture of gene and protein expression from a biological sample
WO2023034489A1 (en) 2021-09-01 2023-03-09 10X Genomics, Inc. Methods, compositions, and kits for blocking a capture probe on a spatial array

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906561A (en) * 1981-09-14 1990-03-06 Thornthwaite Jerry T Nuclear isolation medium and procedure for separating cell nuclei
US5498520A (en) * 1992-02-10 1996-03-12 Baxter International Inc. Method for testing blood units for viral contamination
US5545528A (en) * 1993-04-15 1996-08-13 Hitachi Chemical Research Center Rapid screening method of gene amplification products in polypropylene plates
US5595879A (en) * 1991-08-08 1997-01-21 Arizona Board Of Regents For And On Behalf Of The University Of Arizona Multi-domain DNA ligands for protein and nucleic acid affinity chromatography and processing of solid-phase DNA
US5652141A (en) * 1990-10-26 1997-07-29 Oiagen Gmbh Device and process for isolating nucleic acids from cell suspension
US5656462A (en) * 1992-01-29 1997-08-12 Hitachi Chemical Co., Ltd. Method for synthesizing cDNA using a polynucleotide immobilized support
US5990298A (en) * 1997-09-12 1999-11-23 The University Of Connecticut CIS-acting cellular nucleic acid molecules
US6020186A (en) * 1990-10-26 2000-02-01 Qiagen Gmbh Device and process for isolating nucleic acids from cell suspensions
US6277648B1 (en) * 1991-12-02 2001-08-21 Qiagen Gmbh Process and a device for the isolation of cell components such as nucleic acids from natural sources
US20020010323A1 (en) * 1998-10-09 2002-01-24 Andrew Martin Mitchell Isolation method and apparatus
US20020039783A1 (en) * 1998-12-24 2002-04-04 Cepheid Device and method for lysing cells, spores, or microorganisms
US6495319B1 (en) * 1998-04-27 2002-12-17 Sidney Kimmel Cancer Center Reduced complexity nucleic acid targets and methods of using same
US20030152998A1 (en) * 1997-12-22 2003-08-14 Masato Mitsuhashi Method of preparing cell lysate
US20040072193A1 (en) * 2000-10-31 2004-04-15 Masato Mitsuhashi Method for collecting and using nuclear mrna

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04187077A (en) 1990-11-22 1992-07-03 Shimadzu Corp Apparatus for extraction and purification of nucleic acid
CA2122450C (en) 1991-11-01 2004-07-13 Charles Phillip Morris Solid phase amplification process
DK72493D0 (en) 1993-06-18 1993-06-18 Risoe Forskningscenter SOLID SUPPORTS FOR USE IN PEPTIDE SYNTHESIS AND ASSAYS
GB9314249D0 (en) 1993-07-09 1993-08-18 Proofname Ltd Purification method and apparatus
US5556771A (en) 1995-02-10 1996-09-17 Gen-Probe Incorporated Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
GB9507238D0 (en) 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
WO1996041810A1 (en) 1995-06-08 1996-12-27 Progen Industries Limited Method and apparatus for dna extraction
EP0814156B1 (en) 1996-06-18 2003-03-05 The Institute Of Physical & Chemical Research Method for the purification of DNA
IL129872A0 (en) 1996-11-12 2000-02-29 Qbi Entpr Ltd Method for identifying translationally regulated genes
DE69839734D1 (en) 1997-12-22 2008-08-28 Hitachi Chemical Co Ltd Direct RT-PCR on microtiter plates with immobilized oligonucleotide
US7745180B2 (en) * 2002-04-24 2010-06-29 Hitachi Chemical Co., Ltd. Device and method for high-throughput quantification of mRNA from whole blood

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906561A (en) * 1981-09-14 1990-03-06 Thornthwaite Jerry T Nuclear isolation medium and procedure for separating cell nuclei
US5652141A (en) * 1990-10-26 1997-07-29 Oiagen Gmbh Device and process for isolating nucleic acids from cell suspension
US6020186A (en) * 1990-10-26 2000-02-01 Qiagen Gmbh Device and process for isolating nucleic acids from cell suspensions
US5595879A (en) * 1991-08-08 1997-01-21 Arizona Board Of Regents For And On Behalf Of The University Of Arizona Multi-domain DNA ligands for protein and nucleic acid affinity chromatography and processing of solid-phase DNA
US6277648B1 (en) * 1991-12-02 2001-08-21 Qiagen Gmbh Process and a device for the isolation of cell components such as nucleic acids from natural sources
US5656462A (en) * 1992-01-29 1997-08-12 Hitachi Chemical Co., Ltd. Method for synthesizing cDNA using a polynucleotide immobilized support
US5498520A (en) * 1992-02-10 1996-03-12 Baxter International Inc. Method for testing blood units for viral contamination
US5545528A (en) * 1993-04-15 1996-08-13 Hitachi Chemical Research Center Rapid screening method of gene amplification products in polypropylene plates
US5990298A (en) * 1997-09-12 1999-11-23 The University Of Connecticut CIS-acting cellular nucleic acid molecules
US20030152998A1 (en) * 1997-12-22 2003-08-14 Masato Mitsuhashi Method of preparing cell lysate
US6844158B1 (en) * 1997-12-22 2005-01-18 Hitachi Chemical Co., Ltd. Direct RT-PCR on oligonucleotide-immobilized PCR microplates
US6495319B1 (en) * 1998-04-27 2002-12-17 Sidney Kimmel Cancer Center Reduced complexity nucleic acid targets and methods of using same
US20020010323A1 (en) * 1998-10-09 2002-01-24 Andrew Martin Mitchell Isolation method and apparatus
US20020039783A1 (en) * 1998-12-24 2002-04-04 Cepheid Device and method for lysing cells, spores, or microorganisms
US20040072193A1 (en) * 2000-10-31 2004-04-15 Masato Mitsuhashi Method for collecting and using nuclear mrna

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968288B1 (en) 2002-04-24 2011-06-28 Hitachi Chemical Co., Ltd. Device and method for high-throughput quantification of mRNA from whole blood
US8101344B2 (en) 2002-04-24 2012-01-24 Hitachi Chemical Research Center, Inc. Device and method for high-throughput quantification of mRNA from whole blood
US8076105B2 (en) 2002-04-24 2011-12-13 Hitachi Chemical Research Center, Inc. Device and method for high-throughput quantification of MRNA from whole blood
US20060199212A1 (en) * 2002-04-24 2006-09-07 Masato Mitsuhashi Device and method for high-throughput quantification of MRNA from whole blood
US7981608B2 (en) 2002-04-24 2011-07-19 Hitachi Chemical Co., Ltd. Device and method for high-throughput quantification of MRNA from whole blood
US7745180B2 (en) 2002-04-24 2010-06-29 Hitachi Chemical Co., Ltd. Device and method for high-throughput quantification of mRNA from whole blood
US7939300B2 (en) 2002-04-24 2011-05-10 Hitachi Chemical Co., Ltd Device and method for high-throughput quantification of mRNA from whole blood
EP2058405A1 (en) * 2003-10-30 2009-05-13 Hitachi Chemical Company, Ltd. Device and method for high-throughput quantification of mRNA from whole blood
WO2005042784A3 (en) * 2003-10-30 2005-10-13 Hitachi Chemical Co Ltd Device and method for high-throughput quantification of mrna from whole blood
US7943294B2 (en) 2004-07-30 2011-05-17 Hologic, Inc. Methods for detecting oncofetal fibronectin
WO2006026020A2 (en) 2004-07-30 2006-03-09 Adeza Biomedical Corporation Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
US20060024757A1 (en) * 2004-07-30 2006-02-02 Robert Hussa Detection of oncofetal fibronectin for selection of concepti
US8372581B2 (en) 2004-07-30 2013-02-12 Cytyc Corporation Methods for detecting oncofetal fibronectin
US9513298B2 (en) 2004-07-30 2016-12-06 Hologic, Inc. Methods for detecting oncofetal fibronectin
US20090137406A1 (en) * 2006-06-07 2009-05-28 Kenji Kinoshita RNA Detection Method
US8088580B2 (en) 2006-06-07 2012-01-03 Sumitomo Bakelite Company, Ltd. RNA detection method
WO2012040500A3 (en) * 2010-09-22 2012-05-24 Hoon Dave S B Direct blood assay for detection of circulating microrna in cancer patients

Also Published As

Publication number Publication date
US6844158B1 (en) 2005-01-18
US7258976B2 (en) 2007-08-21
US20030152998A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
US7258976B2 (en) Method of preparing cell lysate
EP1865074B1 (en) Direct RT-PCR on oligonucleotide-immobilized PCR microplates
EP0676476B1 (en) Isothermal strand displacement nucleic acid amplification
WO2021155057A1 (en) Barcoded wells for spatial mapping of single cells through sequencing
JP2019500856A (en) Apparatus and method for pooling samples from multiwell devices
US20050003369A1 (en) Method for depleting specific nucleic acids from a mixture
JP2005511030A (en) Nucleic acid amplification method
RU2753883C2 (en) Set of probes for analyzing dna samples and methods for their use
JP2012055311A (en) Generic buffer for amplification
CN111757934A (en) Target enrichment by one-way dual probe primer extension
JP2006504440A (en) Improved method for making multiple RNA copies
US20200377928A1 (en) Method of detecting minor bcr-abl1 gene
EP0753074B1 (en) Method for reducing background signals in dna replication/detection assays
US20060240431A1 (en) Oligonucletide guided analysis of gene expression
WO2012045669A1 (en) Method for cell lysis and pcr within the same reaction vessel
US6485916B2 (en) Preparation method of nucleic acid sample for rare expressed genes and analyzing method using the prepared nucleic acid samples thereby
US20220136042A1 (en) Improved nucleic acid target enrichment and related methods
WO2024013241A1 (en) Variant allele enrichment by unidirectional dual probe primer extension
WO2023170144A1 (en) Method of detection of a target nucleic acid sequence
JP2020520664A (en) Multiplex nucleic acid amplification assay
MXPA97003730A (en) Detection of nucleic acids in cells by the method of amplification of the hebra by displacement, in a thermofil reaction

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION